STRUCTURALLY SUPPORTED CELL-LADEN SCAFFOLDS FOR BONE TISSUE REGENERATION by Sawyer, Stephen William
Syracuse University 
SURFACE 
Dissertations - ALL SURFACE 
December 2018 
STRUCTURALLY SUPPORTED CELL-LADEN SCAFFOLDS FOR 
BONE TISSUE REGENERATION 
Stephen William Sawyer 
Syracuse University 
Follow this and additional works at: https://surface.syr.edu/etd 
 Part of the Engineering Commons 
Recommended Citation 
Sawyer, Stephen William, "STRUCTURALLY SUPPORTED CELL-LADEN SCAFFOLDS FOR BONE TISSUE 
REGENERATION" (2018). Dissertations - ALL. 978. 
https://surface.syr.edu/etd/978 
This Dissertation is brought to you for free and open access by the SURFACE at SURFACE. It has been accepted for 
inclusion in Dissertations - ALL by an authorized administrator of SURFACE. For more information, please contact 
surface@syr.edu. 
ABSTRACT 
 
Due to challenges associated with current clinical techniques used to treat bone defects, there has 
been an increased focus on finding a tissue engineered solution.  However, while great progress in 
this field has been achieved, researchers have yet to suitably combine the proper biological and 
structural environments needed to serve as a complete bone tissue substitute that is comparable to 
modern clinical solutions.  
 
To achieve the goal of creating a model bone tissue substitute which could eventually serve as a 
viable therapy for bone trauma, be it caused by congenital medical conditions, age related diseases 
or high impact forces, three areas of the engineered construct architecture and composition were 
identified and studied in a successive fashion.  First, a soft, biocompatible matrix within which 
cells could be encapsulated was studied, followed by an investigation on how to combine the soft 
matrix with a 3D printed structural frame.  Finally, user-defined perfusable vasculature was added 
to the soft matrix in order to create a model bone tissue engineering construct capable of possible 
in vivo implantation. 
 
In Chapter 2 of this work, osteoblast-like human osteosarcoma cells (Saos-2) were encapsulated 
within gelatin methacrylate (GelMA) hydrogels and the effect of the hydrogel density on cellular 
morphology and mineralization was investigated.  It was found that the less dense hydrogels 
allowed for increased cell viability and spreading, while the denser gels appeared to encourage 
more mineral deposition on the construct periphery. 
 
Building upon Chapter 2, Chapter 3 focused on the 3D printing of polycaprolactone (PCL) and 
composite PCL cages which could be combined with the soft GelMA matrices used for cellular 
encapsulation.  It was found that while PCL and PCL composite cages could be reproducibly 
printed via a Makerbot 3D printer, the structural strengths did not surpass those of standard poly 
lactic acid (PLA) thermoplastic cages.  Furthermore, it was demonstrated that the cell-laden 
GelMA hydrogels containing encapsulated Soas-2 cells could be incorporated with the 3D printed 
structures for potential bone tissue engineering applications. 
 
In Chapter 4, a simpler version of the cages produced in Chapter 3 were combined with sacrificial 
3D printed polyvinyl alcohol (PVA) pipes and the dense cell-laden hydrogels investigated in 
Chapter 2 to create structurally supported, cell-laden hydrogel constructs.  It was found that 
encapsulated cells could be stimulated to deposit mineral in the centers of the constructs via direct 
perfusion.  However, in a larger version of the construct containing multiple pipes, mineralization 
was impeded due to diffusion issues caused by individual channel mineralization. 
 
Finally, in Chapter 5 future strategies to improve upon the structurally supported cell-laden 
hydrogels are discussed which would solve the issues found in Chapter 4.  Additionally, potential 
in vivo applications for this system are explored. 
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 1 
CHAPTER 1:  INTRODUCTION 
 
1.1 The need for bone tissue engineering 
 
Over the past decade, there has been an increased focus on providing a tissue engineered solution 
for orthopedic bone defects which cannot heal properly.  These types of defects, many of which 
involve bone fracture, can be caused by birth disorders, tumors, infections, revision surgeries, and 
high impact traumas and pose a large financial burden on the medical community.[1-5]  In fact, as 
of 2010 the American Academy of Orthopedic Surgeons estimated that there were over 6 million 
fractures annually in the United States alone resulting in hundreds of thousands of bone graft 
procedures costing approximately $2.5 billion dollars.[4, 6]   
 
It has been estimated that approximately 10% of all bone fractures do not heal properly and 
therefore require clinical intervention.[5]  These types of segmental bone defects, which are 
commonly referred to as critically sized defects, include fractures that either cannot heal naturally 
without intervention, regenerate less than 10% over the course of the lifetime of the injury, or are 
approximately 2 to 3 times larger than the diameter of the injured bone.[6]  As segmental bone 
defects come in different shapes and sizes, there are a range of clinical techniques used to aid the 
bone healing process.  In general, these solutions rely on either vascularized autografts, allografts, 
synthetic implants, or specialized techniques such as distracted osteogenesis[1, 6-8]. 
 
The preferred treatment of a segmental bone defect is a vascularized bone graft, such as pedicled 
vascularized bone graft used in repairing broken wrists or fractures in the femoral neck and hip.[6, 
9]  These types of grafts are harvested from the patient itself and include host vasculature, thereby 
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allowing for direct anastomosis to the local blood supply.  Vascularized bone grafts have been 
shown to dramatically enhance healing times, however they do include drawbacks such as donor 
site morbidity and the  necessity of shielding the surgical site from weight bearing applications 
during the healing process.[6, 9, 10] 
 
Due to the donor morbidity associated with vascularized bone grafts, allografts are a widely 
available solution as they are not patient derived.[1]  Additionally, allografts can serve as solutions 
to fractures that will necessitate load bearing post-surgery, making them an attractive option in the 
treatment of a segmental defects.[1, 6]  However, as allografts are not vascularized and the material 
is not patient specific, concerns such as disease transmission, the possibility of implant failure, and 
on rare occasions host rejection, remain.[6] 
 
Implants are another common solution to repairing segmental bone defects and can be made from 
a variety of materials.  For instance, intramedullary nails, which are the standard of care for injuries 
such as tibial shaft fractures, have been shown to be highly biocompatible.[5, 8]  However, as the 
implants are generally not made from organic material, the possibility of corrosion, wear, and 
fibrous encapsulation remain issues that could lead to implant failure or secondary surgery.[11, 
12]  Fortunately, implants made of stainless steel and titanium have mitigated these concerns 
greatly. 
 
Techniques such as distraction osteogenesis have also been used to treat segmental bone defects 
with great success.[6, 13]  In this particular technique, the cortical shell of the fractured bone is 
cut, leaving the periosteum and medullary cavity intact.[6]  The cut is then stabilized with an 
external fixator that extends the bone segment between the cut and the defect at a rate of 1mm/day, 
 3 
thereby “distracting” the natural callus formed during bone repair.[6, 14]  Essentially, the 
“distraction” of the callus stimulates bone formation de novo through both mechanical and 
biological stimulation, and eliminates the need for graft material.[14]  However, while the external 
fixator makes weight bearing possible, its application may be extremely cumbersome to the patient 
and the time frame for healing could be prolonged.[6] 
    
Autografts, whether they are vascularized as explained before or avascular, remain the current gold 
standard for bone replacement in a clinical setting.[15]  Not only are they harvested from host 
material, but they generally include the inherent structure and growth factors needed for bone 
repair.[6]  However, while autografts provide an excellent option for the repair of segmental 
defects, they do still have drawbacks such as donor site morbidity and limited availability in elderly 
patients.[6]  As such, researchers have attempted to find possible alternative solutions in the form 
of tissue engineered constructs.  For instance, in one such case a b-tricalcium phosphate matrix 
combined with recombinant human homodimeric PDGF subunit B, a peptide signaling molecule 
involved in bone repair, were compared against autografts in ankle arthrodesis cases.[16]  It was 
shown that while the fusion rates were similar between the two groups, the PDGF constructs 
seemed to reduce the patient pain.  Regardless, while current clinical practices for the repair of 
segmental bone defects have been very successful, they do all have their own drawbacks and 
research into alternative solutions, such as tissue engineered constructs, is necessary to improve 
patient care and advance the field of orthopedics.[5] 
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1.1.1 Creating a tissue engineered solution 
 
The noted issues associated with clinical approaches to treat segmental bone defects and fractures 
highlight the need for a robust and reproducible tissue engineered bone replacement.  More 
specifically, this replacement must be capable of providing a suitable microenvironment which not 
only is able to house appropriate cells for regenerative purposes, but also capable of recruiting 
cells in vivo to support a complete restoration of the defective bone tissue.[7]  Not only will this 
improve the quality of life for those maligned with orthopedic defects of any kind, but will 
hopefully reduce the burden on healthcare systems around the world.  However, before attempting 
to create a tissue engineered solution, the complex architecture of native bone needs to be 
understood. 
 
1.2 The structure and composition of bone 
 
Bone is a hard, composite tissue which houses the body’s organs, provides the structural support 
needed for the body’s motion, and serves as the calcium repository for the human body.[17]  
Additionally, due to advances in bone biology over the past decade, bone has also been identified 
as an endocrine organ which is vital in regulating the body’s glucose and testosterone levels.[17]    
As such, not only must a healthy human skeleton have sufficient structural properties, it must also 
be capable of continuous adaptation and remodeling through complex interplays between cellular, 
organic, and inorganic components.[17, 18] 
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1.2.1 Cellular component 
 
There are three main types of bone cells which reside within the bone hierarchy that derive from 
either the mesenchymal or hematopoietic stem cell lineages. Two of these cells, osteoclasts and 
osteoblasts, are directly responsible for the bones ability to remodel itself over time via coupled 
actions.[6, 18]  The first cell, called osteoclasts, are multinucleated cells which originate from 
mononuclear hematopoietic stem cells and are responsible for the resorption stage of bone 
remodeling.[19-21]  Osteoclast precursor cells are found circulating in the blood and, when 
stimulated through a combination of signals expressed by osteogenic lineage cells such as receptor 
activator of nuclear factor-kb ligand (RANKL) and macrophage colony-stimulating factor (M-
CSF), fuse together into large multinucleated osteoclasts.[6, 18, 19]  Once fused, mature 
osteoclasts attach to the surface of the bone via anb3 integrins and acidify the environment on the 
bone surface through H+ATPase-mediated extracellular proton transport, leading to the breaking 
down of the organic and inorganic bone components.[18, 21, 22]  The second type of bone cells, 
called osteoblasts, originate from the non-haematopoietic cells within the bone marrow.[6]  Once 
osteoblasts are mature, they are primarily responsible for secreting osteoid, the main organic 
component of bone which contains primarily type-I collagen and other non-collagenous 
proteins.[20]  As the resorbed bone is replaced by the osteoblasts, a process that can take up to 3 
months, mature osteoblasts follow one of three paths.[20, 23]  Some of the osteoblasts will flatten, 
become quiescent, and line the surface of the newly formed bone, while others will simply die via 
apoptosis.[23, 24]  The third pathway, however, gives rise to the third bone cell type, called the 
osteocyte.  Osteocytes are osteoblasts which have become encased within the lacunae of 
mineralized osteoid bone matrix.[21] Osteocytes, which comprise 90 percent of the total number 
of bone cells within the skeleton, develop long dendritic processes which facilitate communication 
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between other cells in the mineralized matrix and the bone lining cells via microscopic channels 
between the lacunae called canaliculi.[20, 21, 25]  
 
1.2.2 Bone matrix 
 
The bone matrix is a complex combination of organic and inorganic components and comprises 
approximately 90% of the entire tissue volume, the rest of which is taken up by cells and blood 
vessels.[20, 21, 26]  The organic matrix component, which is mainly a combination of different 
forms of collagen, accounts for about 20% of the matrix and gives the bone tensile strength.[20, 
21, 26]  The inorganic matrix component, which is the mineral component of bone, is responsible 
for approximately 65% of the matrix by weight and is responsible for the bones compressive 
strength.[20, 21, 27] 
 
Type I collagen accounts for roughly 90% of the entire organic matrix component, the rest of 
which is a mixture of type V and XII collagen and several non-collagenous proteins.[20, 21, 28]  
Of the non-collagenous proteins, osteocalcin is the most abundant as it is readily secreted by 
osteoblasts and has a high binding affinity to hydroxyapatite mineral.[21, 29]  Furthermore, 
osteocalcin has been shown to be a key regulator of glucose metabolism and testosterone levels 
within the body, thereby making the skeleton an endocrine organ.[17]  Osteopontin is the second 
most abundant non-collagenous protein in the bone matrix and is secreted by numerous bone cells 
and progenitors.  Due to its acidic nature, osteopontin readily binds Ca+2 ions and is responsible 
for both the suppression and promotion of mineral formation.  Additionally, osteopontin contains 
numerous Arg-Gly-Asp (RGD) motifs and readily aids cell adhesion and movement.[21, 30]  Other 
notable proteins found in the bone matrix include bone phosphoproteins, bone sialoprotein, and 
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numerous proteoglycans which all are attributed to regulating how cells interact with the matrix, 
how cells communicate with one another, and how mineralization occurs.[20, 26] 
 
The inorganic components of bone are a combination of numerous ions and a form of apatite 
mineral.  Ca2+, PO43- and CO32- are among the main ions found in the bone, along with Mg2+, Fe2+, 
Na+, K+, F- and Cl- and serve as the major reservoir source for the rest of the bodies calcium and 
phosphorous.[20, 21, 31]  Apatite mineral, which is the major inorganic component, comprises 
approximately 65% of the total mass of the bone[32] and is not pure hydroxyapatite 
(Ca10(PO4)6(OH2)2), but rather a form of apatite that contains acid phosphate groups and carbonate 
ions but no hydroxyl groups.[20, 21]  
 
1.2.3 Cortical and cancellous bone 
 
Natural bone consists of hard cortical bone, spongy cancellous bone, and bone marrow.  Cortical 
bone, which has a high mechanical strength and comprises the outer hard layer of bone, is 
responsible for approximately 80% of the human skeleton weight.[21, 33] Cancellous bone, on the 
other hand, has a low mechanical strength as compared to cortical bone and is a porous structure 
that contains bone marrow.  Bone marrow contains stem cells capable of differentiating into 
osteoblasts, adipocytes, chondrocytes and fibroblasts, as well haematopoietic stem cells capable 
of differentiating into myeloid lineage cells, lymphoid lineage cells, and osteoclasts.[34]  
Additionally, it is speculated that since oxygen tension ranges from 1% to about 7% of atmospheric 
oxygen levels within the marrow depending on the location of capillaries, specific niches are 
formed which enable populations of stem cells to remain undifferentiated.[34, 35]  
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Depending on the arrangement of the cortical bone, cancellous bone, and bone marrow, the bones 
in the human skeleton are classified as either long bones, short bones, flat bones, or irregular 
bones.[21]  The first group, long bones, are bones such as the femur and tibia.  These types of 
bones are generally longer than they are wide and consist of a long cortical shaft called the 
diaphysis which surrounds a medullary cavity containing bone marrow.[20]  As you move away 
from the center of the diaphysis of a long bone, referred to as the midshaft, the cortical walls 
become thinner, the bone diameter widens, and there is an increasing amount of cancellous bone 
in the center underneath the cortical shell.[20]  This area of increased cancellous bone is called the 
metaphysis and supports the growth plate, a layer of hyaline cartilage that separates the metaphysis 
from the rounded end of the long bone.[20]  This rounded end, called the epiphysis, is filled with 
cancellous bone and bone marrow and has a layer of articular cartilage directly next to the bone 
joint. 
 
1.2.4 Hierarchy of the long bone  
 
Regardless of the geometrical arrangement of cortical and cancellous bone, their basic hierarchical 
structure is common through all native bone.  As stated previously, osteoblasts secrete osteoid, the 
mineralized extracellular matrix comprised of collagen and non-collagenous proteins.  The 
collagen polymerizes quite rapidly to form collagen fibrils that serve as the deposition points for 
apatite crystals.  Alkaline phosphatase, an enzyme which is also secreted by osteoblasts, aids in 
phosphate and calcium deposition and causes a rather organized crystal deposition along these 
collagen fibrils.[31]  These mineralized collagen fibrils are packed tightly in lamellar units and 
represent the basic hierarchical unit for mature cortical and cancellous bone. 
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In cancellous bone, the lamellar units are arranged in functional units called trabeculum.  
Geometrically, the trabeculae are arranged as a porous mesh of rods and struts that increase the 
compressive strength of the bone.  The orientation of the trabeculae change over time in a highly 
organized way to support the areas of the bone that experience the most strain.[21] 
 
Similar to cancellous bone, the lamellar units also form the functional unit of cortical bone called 
the osteon. Osteons, which are anywhere from 100 to 500 µm in diameter, are formed by concentric 
rings of lamellar units surrounding a central channel containing blood vessels and nerves called 
the Haversian canal.[20, 36]  Within each lamellar ring, the collagen fibers are oriented parallel to 
each other, but run in different directions to adjacent lamellar units.[21]  Osteocytes are located in 
lacunae within the lamellar rings and extend processes radially outwards from the Haversian canal 
through a network of canaliculi, thereby ensuring the diffusion of nutrients throughout the bone 
tissue as well as providing a mechanosensation communication network capable of passing signals 
throughout the bone structure.[20, 25]  At the edges of osteons is a thin sheet of bone matrix called 
the cement line within which most canaliculi and collagen fibers stop, essentially isolating each 
osteon from one another.[20, 25]  Running transverse throughout the osteon network within 
cortical bones are small channels called Volkmann’s canals that effectively connect the vertical 
Haversian network.  Additionally, since these small canals run the entirety of the cortical bone, 
they serve to transmit blood vessels and nutrients from the outside periosteum surrounding the 
bone to the endosteal surface surrounding the cancellous bone, thereby creating the vascular lining 
of the medullary cavity.[21, 36] 
 
The periosteum is a thin sheet of highly vascularized tissue which surrounds the outer surface of 
bone.  Structurally, the periosteum is comprised of an outer fibrous layer and an inner vascularized 
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cellular layer.  The inner layer, also called the osteogenic layer, contains cells that are capable of 
differentiating into osteoblasts while the outer layer connects bones to tendons and ligaments.[20, 
25] 
 
1.3 Bone vasculature and its role in bone growth and homeostasis 
 
Although much of the focus on the bone hierarchy revolves around its load bearing structure, 
healthy bone is also highly vascularized.  In order to provide adequate nutrients and oxygen to the 
tissue, as well as ensure the removal of metabolic waste, bone contains an intricate vascular 
network that receives up to 11% of the total cardiac output of the human body.[34, 37]  In fact, in 
native bone the vascular network is arranged in such a way that no area is further than 100 µm 
from a nutrient source, ensuring that the diffusion of nutrients and systemic signaling molecules is 
not impeded to any bone cells.[2, 38] 
 
There are four main regions of arterial input into the human long bone: the diaphyseal nutrient 
arteries, the metaphyseal arteries, the epiphyseal arteries, and the periosteal arteries.[2, 39]  The 
largest arteries are the diaphyseal nutrient arteries which supplies up to 50% of all blood to the 
human long bone and enter into the central medullary cavity as well as regions of the metaphysis 
and cortex.[2]  The diaphyseal nutrient arteries, which are located on the outer bone cortex, enter 
the medullary canal through small openings called foramina and are generally accompanied by 
large veins.  As these arteries pass through the cortical bone, they branch into the Haversian and 
Volkmann canals in the osteons, and sinusoids within the marrow.[2, 40]  Similar to the diaphyseal 
nutrient arteries, the metaphyseal and epiphyseal arteries enter into the epiphysis and metaphysis 
through their respective vascular foramina and serve to reinforce the vascular branches from the 
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diaphyseal arteries.  Finally, the periosteal arteries, which are located on the inner side of the highly 
vascularized periosteum, enter the long bone through the Volkmann canals to supply the areas of 
the cortex not supplied via the diaphyseal arteries.[2]  After circulating through the bone, the blood 
leaves through the central sinus veins.[2, 41] 
 
In addition to providing nutrient exchange and waste removal, the bone vasculature is a key 
component to bone growth and remodeling, as well as fracture repair.  In all three instances, the 
vasculature, or lack thereof, can be considered the regulatory force for how the bone is grown or 
repaired. 
 
1.3.1 New bone growth 
 
Bone is formed by intramembranous and endochondral ossification, depending on the type of bone 
being formed.  Intramembranous ossification is the method in which flat bones are formed while 
long bones are formed by both intramembranous and endochondral ossification.[42, 43]  In both 
instances, however, vasculature, or the lack thereof, mediates the growth process. 
 
In intramembranous ossification, the growth space is first invaded by capillaries that are followed 
by mesenchymal cells which differentiate into osteoblasts.  These first osteoblasts form a cluster, 
called the ossification center, and proceed to secrete osteoid which hardens within a few days.  As 
the osteoblasts within the hardened ossification center differentiate into osteocytes, new 
osteoblasts form on the outside edges of the new bone.  This process continues, and the new bony 
matrix begins to fuse together around the capillaries creating the trabeculae of the newly formed 
cancellous bone.  As the trabecular matrix continues to grow, osteoblasts and other mesenchyme 
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cells continue to aggregate on the outside of the trabeculae and form the beginning layer of a new, 
highly vascularized periosteum.  Eventually, osteogenic cells from the periosteum form cortical 
hard bone surrounding the cancellous tissue.[42, 43] 
 
Unlike intramembranous ossification, endochondral ossification occurs as vasculature invades 
cartilage regions.  In new long bone formation, the mesenchymal cells originally differentiate into 
chondrocytes which create a cartilage template that will slowly be replaced by bone.  Surrounding 
the growing cartilage template of the new bone are a group of mesenchymal cells which form the 
perichondrium that will eventually become the periosteum of the long bone.[2, 43, 44]  As the 
region of cartilage grows through chondrocyte proliferation and secretion of type II collagen, the 
chondrocytes in the center enlarge into hypertrophic chondrocytes.[44]  The hypertrophic 
chondrocytes attract blood vessels from the surrounding perichondrium via the release of vascular 
endothelial growth factors, thereby causing blood vessels to invade the hypoxic cartilage 
environment and, as was also seen in intramembranous ossification, bring with them mesenchymal 
cells which differentiate into osteoblasts.[2, 43, 44]  As the osteoblasts and vasculature continue 
to aggregate and replace the cartilage and chondrocytes in the center of what will eventually be 
the medullary cavity of the long bone diaphysis, they begin depositing bone within the structure, 
creating what is called the primary ossification center.[2, 43, 44]  As bone and vasculature replace 
the cartilage in the diaphysis of the newly forming long bone, chondrocytes and cartilage continue 
to grow outward from the primary ossification center, elongating the bone and creating what will 
eventually be the proximal and distal epiphysis of the bone.[2, 43]  The remodeling and 
organization in the diaphysis continues as osteoclasts are recruited, and the reorganization that 
occurred in the medullary repeats in the two epiphyseal regions, creating secondary ossification 
centers.[2, 43, 44]  In long bones, chondrocytes continue to grow and proliferate between the 
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primary and secondary ossification centers and form a flattened, disc shape of collagen which 
directs bone growth, called the growth plate.[44]  On the edges of the growth plates, chondrocyte 
proliferation drops and the chondrocytes serve as a reservoir for future growth.[44]  
 
1.3.2 Bone remodeling 
 
As stated previously, osteoblasts and osteoclasts are the two main bone cells involved in bone 
remodeling, a process that occurs though the entire lifespan of bone.[2]  However, while the 
osteoblasts and osteoclasts are generally the focus of the remodeling process, the bone vasculature 
serves as a key mediator and is integral to the bone metabolic unit (BMU) within which remodeling 
takes place.[23]  In fact, it has been shown that when the blood supply is inhibited or damaged, 
necrosis and bone loss occurs as bone remodeling is impaired.[34] 
 
The bone remodeling process is fairly well defined in the context of the aforementioned BMUs.  
As bones age, mature osteoblasts lose their ability to secrete osteoprotegerin (OPG), a cytokine 
decoy receptor that binds to RANKL, a ligand also secreted by osteoblasts.  Without OPG 
competition for RANKL, RANKL is free to bind to osteoclast progenitor cell RANK receptors, 
thereby allowing for osteoclast differentiation and activation.[2, 23]  Accordingly, when areas of 
cortical and cancellous bone age, osteoclasts are signaled to begin resorption and begin resorbing 
bone in a trench like fashion called a Howship lacunae.[2, 23]  As the resorption is occurring, 
mesenchymal osteoprogenitors are directed into the BMU and begin new bone deposition in the 
resorbed surface, a process that can take up to 3 months to complete.[2, 23]   
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1.3.3 Fracture repair 
 
As can be expected, the normal stages of fracture repair are also highly tied to the bone vasculature.  
Unlike soft tissue, bone undergoes a complex healing process that involves intramembranous and 
endochondral bone formation as well as bone remodeling, all of which are dependent on a healthy 
skeletal vasculature.[2]  More specifically, when a fracture occurs, the damage to the intraosseous 
vasculature and periosteum are what initially drives the regenerative process. 
 
When a fracture occurs, the blood supply of the bone is disrupted, leading to hypoxic conditions 
in the surrounding tissue.[34, 39]  In the first stage of repair, the blood around the injury clots, 
forming a hematoma, and the surrounding tissue becomes inflamed.[42, 45] The hypoxic 
conditions are extremely important in this first phase of fracture repair as they create a cascade of 
events which cause a release of several growth factors and cytokines that recruit endothelial cells 
and direct cellular differentiation.[2] As the hematoma is formed, hypoxic osteoblasts release 
vascular endothelial growth factor (VEGF) which stimulates angiogenesis through the recruitment 
of endothelial cells.[46]  However, as endothelial cells are recruited to the fracture site, stem cells, 
and inflammatory cells, such as neutrophils, travel alongside the invading vasculature.[46, 47]  The 
inflammatory cells release proangiogenic cytokines which aid in capillary repair while the VEGF 
stimulates the invading endothelial cells to release osteogenic cytokines that promote osteoblast 
differentiation and recruitment.[46]  As the cells within the hematoma die, invading fibroblasts 
form a loose connective tissue, called granulation tissue, in the injury site alongside the newer 
blood vessels.[39]  Eventually, this tissue is replaced by fibrocartilage as the hypoxic environment 
drives the differentiation of chondrocytes, thereby stabilizing the fracture and forming the internal 
callus.[2, 42]  Concurrent to the internal callus forming, the periosteum begins to undergo 
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intramembranous bone formation, leading to the creation of an external callus.[39, 42]  The two 
calluses eventually combine and form a stabilizing large fracture callus.  Once the fracture callus 
has formed, the internal callus is replaced by woven bone, which unlike lamellar bone is an 
irregular grouping of collagen.[20, 39]  After the formation of this hard callus, the bone remodeling 
process begins and the fracture callus is gradually replaced with lamellar bone.[39]   
 
1.4 Challenges of developing a tissue engineered construct 
 
In order to create a tissue engineered bone substitute, numerous variables need to be taken into 
account.  A complete solution must be capable of supporting the numerous multicellular 
interactions required for functional bone growth, must address the structural complexity of bone, 
and must contain a defined vasculature or porosity capable delivering nutrients in a controlled and 
ordered way.[48-52]  Unfortunately, a complete solution which incorporates all of these areas has 
not been developed. 
 
1.4.1 Challenge 1 – Soft matrix for cellular encapsulation 
 
Traditional strategies for bone tissue engineering have relied upon creating scaffolds that provide 
structural support containing seeded osteo-competent cells.[53]  Hard bioceramics such as 
hydroxyapatite and calcium phosphate have shown good strength and integration with native bone, 
but seeding cells post manufacturing sometimes result in an inhomogeneous distribution of 
cells.[53, 54]  Additionally, with the lack of a well-defined vasculature and proper nutrient 
exchange, such approaches generally result in construct mineralization only at the peripheries of 
the scaffold and the presence of a necrotic core.[2, 55] 
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One popular manufacturing approach in bone tissue engineering that has received increased 
attention over the past decade involves cellular encapsulation within a soft biomaterial.  In general, 
cellular encapsulation usually involves either synthetic or natural hydrogels with which cells can 
be incorporated into the matrix de novo. Additionally, cellular encapsulation can allow for the cells 
to be incorporated at specific locations and densities within the construct, thereby improving upon 
the cell seeding limitations previously mentioned.[56-59]  
 
In the context of creating a bone tissue substitute, it is necessary to ensure that the base material 
not only closely mimics the native bone extracellular matrix, but also supports cell viability and 
proper tissue growth.  As 90% of the organic bone extracellular matrix is comprised of collagen, 
naturally derived biomaterials such as gelatin are widely used as a starting material.[60]  More 
specifically, collagen derived cross-linkable hydrogels such as gelatin methacrylate (GelMA) are 
extremely attractive as scaffold materials for bone tissue engineering due to the fact that they have 
tailorable mechanical properties, exhibit minimum immunogenicity, are biodegradable, and have 
tunable porosities needed for proper nutrient diffusion.[58-61]   
 
Although cell encapsulation within a hydrogel is an appealing approach for the incorporation of 
relevant cells and growth factors into a bone tissue substitute, several issues need to be addressed.  
First, it is important to know how encapsulated cells function and remodel the hydrogel 
environment, as well as how the encapsulation process influences cellular viability and function.  
Additionally, in order to create a clinically relevant scaffold for bone tissue engineering, both the 
hydrogel biocompatibility as well as load bearing capacity needs to be taken into account, 
 17 
indicating that the soft hydrogel would need to be encased in a load bearing material for in vivo 
applications.[62, 63] 
 
1.4.2 Challenge 2 – Strategies for combining soft and hard components 
 
While cellular encapsulation provides a means for the reliable spatial distribution of cells within a 
hydrated construct, the structural integrity and load bearing capabilities of hydrogels are not 
sufficient when creating a possible device for implantation into bone.  Additionally, apart from the 
structural strength of the engineered device, careful attention must be paid to patient-specific 
geometries when designing a possible bone tissue substitute.  Unfortunately, while traditional 
fabrication methods, such as freeze drying, solvent casting, porogen leaching and gas foaming are 
capable of creating macroscopic patient specific geometries for a bone tissue construct, they are 
not compatible with cellular encapsulation and are unable to create constructs containing an 
interconnected, user-defined porosity.[64-66] 
 
In an effort to create hard constructs containing interconnected pores which would be capable of 
supporting cell-laden hydrogels, manufacturing techniques such as laser sintering and Fused 
Deposition Modeling (FDM) have been used.[67, 68]  However, while these techniques are 
capable of creating constructs with interconnected pores, cellular encapsulation would need to 
occur after machining.  Alternatively, photomasking and stereolithography techniques are capable 
of creating soft constructs containing interconnected pores, but do not address the issue of 
combining hard scaffolds with soft internal matrices.[1, 7, 69]  
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With the advent of commercial 3D printing, researchers are now capable of using additive 
manufacturing platforms to create both hard and soft scaffolds that mimic complex 3D 
geometries.[70, 71]  Common materials used for bone tissue engineering scaffolding such as 
hydroxyapatite and polycaprolactone (PCL) are also now able to be transformed into custom made 
spools capable of being used with printers such as MakerBot.[72-74]  More importantly, as 3D 
printing technology has continued to improve, printing hard scaffolds alongside encapsulated cells 
has become a reality.  In one instance, 3D printing was used to print chondrocytes and bone marrow 
cells within alginate hydrogels supplemented with calcium phosphate and hydroxyapatite.[75]  In 
another promising instance, a custom built six nozzle printer was used to print molten PCL 
alongside encapsulated human osteoblasts and chondrocytes in a construct containing porous 
spaces for nutrient diffusion.[76]  However, despite these promising advances in the 3D printing 
of hard constructs containing encapsulated cells, the inability to develop perfusable microvascular 
networks within structures remains a major obstacle in preventing their widespread clinical use. 
 
1.4.3 Challenge 3 – Adding perfusable vasculature 
 
In native bone, perfusion of blood through defined vascular networks separated by only a few 
hundred microns guarantees effective nutrient supply, waste removal, and access of systemic 
signaling molecules to individual bone cells.[20, 41, 77]  Accordingly, by mimicking this 
hierarchical perfusable vascular network within a bone substitute, clinical outcomes could be 
drastically improved by enhancing integration with surrounding host tissue, as well as by allowing 
the restoration of controlled blood flow to the site of the injury.[78, 79] 
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To mimic vascular physiology, integration of user defined channels within cell-laden hydrogels is 
a promising approach that would significantly advance tissue-engineering technologies.[80] 
However, in addition to the inherent manufacturing difficulties presented in the fabrication of user 
defined 3D channels, other issues such as material properties, fabrication times and processes, and 
cellular viability need to be taken into account.[81, 82]   
 
Micro-fabrication techniques such as soft- and photolithography have been used to generate 
hollow microfluidic channels within both synthetic and naturally derived cell-laden hydrogels but, 
while such constructs have shown increased cellular viability while being perfused with media as 
compared to static controls, the fabrication of the 3D channels in user defined patterns is extremely 
difficult.[83-87]  Other types of machining approaches involve methods such as needles[88, 89] 
and sacrificial/fugitive-molding[90] and rely on either needle extraction or the dissolution of 
sacrificial material in order to create hollow channels.  Although these approaches are inexpensive 
and scalable, they are limited by the size of the needle or sacrificial template used. 
 
Advances in 3D printing and additive manufacturing techniques provide an exciting avenue for 
the creation of structurally supportive constructs containing user defined vascular and osteo-
competent cells.  However, while there has been a significant amount of work in this area, a 
complete bone tissue engineering solution has yet to be achieved.  In many instances, the 
combination of sacrificial 3D printed materials such as carbohydrates or pluronics within large 
cell-laden hydrogels has proven successful, but in each case the printed structure was very specific 
to the problem being explored and was either not suitable for bone tissue engineering or difficult 
to modify for different applications.[87, 90-92]   
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1.5 Scope of dissertation 
 
The overarching goal of this work is to develop a comprehensive vascularized bone tissue implant 
to eventually serve as a viable in vivo therapy for a critically sized segmental bone defect. To 
advance that goal, this thesis focuses on the development of a bone tissue model consisting of user 
defined perfusable vascular networks within structurally reinforced hydrogels that are laden with 
osteoblast-like cells. 
 
The introduction, Chapter 1, serves to present a basic view of the structure of bone and highlight 
challenges that must be addressed when developing a bone tissue engineered solution for critical 
bone defects.  Chapter 2 aims to explore the first challenge identified in creating a bone tissue 
substitute and presents a study on how encapsulated osteoblast-like cells interact within a diffusion 
limited gelatin methacrylate hydrogel.  Building upon Chapter 2, Chapter 3 investigates the second 
challenge and presents a study on 3D printed structural cages for cell laden hydrogels and explores 
how the structural cages can be combined with cell-laden hydrogels.  Chapter 4 addresses the third 
identified challenge and focuses on how user defined vasculature can be added to a structurally 
supported cell-laden hydrogel to create a perfusable bone tissue construct.  In Chapter 5, future 
directions and ongoing modifications to the current model presented in Chapter 4 are discussed. 
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CHAPTER 2:  BEHAVIOR OF ENCAPSULATED SAOS-2 CELLS WITHIN GELATIN 
METHACRYLATE HYDROGELSD*[1] 
 
2.1 Abstract  
 
The field of tissue engineering is still seeking a viable substitute to repair and replace damaged 
bone using a combination of porous implants, biochemical factors, and relevant cell types.  
While progress in this field has been made, current engineered solutions have not been able to 
mimic the architectural and biological requirements needed to provide a complete solution.  In 
this work, osteoblast-like human osteosarcoma cells were encapsulated inside gelatin 
methacrylate (GelMA) hydrogels of three different weight/volume (w/v) concentrations and 
stimulated to form mineral in order to determine the relationship between both bone formation 
and cellular activity with matrix density.  Distinct differences between cell morphology and 
mineral formation were found within the three types of hydrogels.  Less dense, low w/v 
constructs were shown to provide a more cell friendly microenvironment that promoted 
dispersed mineral formation while dense, high w/v constructs provided a more structured 
environment for uniform bone-mineral formation.  Additionally, while cells were able to 
function in all three types of hydrogels, cells in the less dense GelMA constructs were shown to 
grow in large colonies within the gelatin matrix while cells in the dense GelMA constructs 
tended to aggregate and grow along the construct peripheries.  
																																																								
DAdapted from:  Sawyer SW, Oest ME, Margulies BS, Soman P.  (2016) Behavior of encapsulated saos-2 cells within gelatin 
methacrylate hydrogels.  Journal of Tissue Science & Engineering 7(2):173. 
*	Reprinted as permitted by the open-access Creative Commons Attribution License	
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2.2 Introduction 
 
 
Bone has emerged as the second most transplanted tissue in the world with forecasted revenue of 
$6.6 billion by 2020 in the United States alone.[2, 3]  While clinical grafts are used in many 
reparative orthopedic procedures, they often fail due to graft necrosis and lack of integration with 
host tissue.[4, 5]  Due to the limited success of such grafts, numerous alternative solutions to 
repairing and regenerating bone have been proposed that consist of combinations of different 
types of porous osteoconductive biomaterials, osteoinductive growth factors, and osteogenic 
cells.[6-9]  However, no single option has emerged as a complete engineered solution.  When 
creating a proper bone tissue substitute, several variables need to be taken into account:  the scale 
of the implant needs to be optimized for proper porosity and nutrient distribution, the base 
material must be biocompatible and biodegradable in ways that promote high cell viability and 
natural tissue growth, and the mechanical support of the implant should be suitable for proper 
weight bearing applications.[3, 8-12]  Current tissue engineering strategies have not been able to 
address all of the aforementioned variables for an organ as intricate as bone.  Traditionally, bone 
tissue engineering has adopted the strategy of creating scaffolds that provide structural support 
followed by the seeding of relevant cells onto the construct post-manufacturing. Although the 
exclusion of living cells during manufacturing gives the flexibility of using a variety of 
fabrication techniques needed to make intricate tissue substitutes, the cell seeding approach relies 
on the ability of cells to infiltrate the interiors of the 3D scaffold and often results in inadequate 
cell dispersion and cellular densities. To address this limitation, another manufacturing approach 
involving cell encapsulation within a soft biomaterial has also been widely explored. Cell 
encapsulation generally utilizes either synthetic or naturally derived hydrogels and includes the 
incorporation of living cells into a hydrated matrix during fabrication, thus allowing for the 
precise control over the cellular density and distribution within a soft 3D construct.[13-16] 
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Although cell encapsulation is an appealing approach for the incorporation of relevant cells and 
growth factors into a bone tissue substitute, several issues need to be addressed.  Not only is it 
important to know how the hydrogel properties influence the viability and function of 
encapsulated osteoblastic cells, it is important to understand how soft hydrated matrices 
influence bone mineral formation.  Furthermore, the soft cell-laden hydrogels need to be 
integrated within a protective, structural frame in order to realize the goal of developing a 
clinically relevant biomimetic construct for bone tissue engineering. In this current study, we 
focus on how encapsulated cells interact within the hydrated microenvironment of a soft bone 
tissue substitute.  To this end, we encapsulate osteoblast-like human osteosarcoma cells (Saos-2) 
inside GelMA hydrogels of varying weight/volume (w/v) concentrations and stimulate them to 
form mineral in order to determine the relationship between bone formation and hydrogel 
density. 
 
2.3 Materials and Methods 
 
2.3.1 Gelatin methacrylate pre-polymer solution preparation   
 
Gelatin methacrylate (GelMA) macromer was synthesized using a previously reported protocol 
to serve as the base hydrogel matrix for cellular encapsulation.[17, 18]   Briefly, porcine skin 
gelatin (Sigma Aldrich) was mixed at 10% (w/v) in phosphate buffered saline (PBS, Thermo 
Fisher Scientific), stirred at 45oC, mixed with methacrylic anhydride, and stirred for 3 hours.  
After stirring, the solution was dialyzed against distilled water for one week at 40˚C, freeze-
dried, and stored at -80°C until needed. For cell encapsulation experiments, three different 
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GelMA pre-polymer solutions (7, 10 and 15% w/v) were created by combining the freeze-dried 
GelMA macromer with various amounts of PBS and 0.25% UV photoinitiator Irgacure 2959 
(Specialty Chemicals, Switzerland).  The pre-polymer solutions were sterile filtered and stored at 
2°C in autoclaved Pyrex bottles (Corning) wrapped with tin foil.  Pre-polymer solutions below 
7% were not used as they were not capable of being photo-cured while pre-polymer solution 
above 15% were not capable of being properly dissolved and sterile filtered. 
 
2.3.2 Saos-2 culture and encapsulation 
 
We employed human osteosarcoma cells (Saos-2; ATCC) transfected with a commercially 
available green fluorescent protein (GFP) lentivirus (Santa Cruz Biotechnology) as analogues for 
osteoblasts since they are a robust cell line capable of being used in the initial stages of new bone 
defect models.  The GFP tagged Saos-2 cells were cultured in Dulbecco’s Modification of 
Eagle’s Media (DMEM; Life Technologies) supplemented with 10% fetal bovine serum (v/v) 
(FBS lot G12102; Atlanta Biologicals), 1% penicillin-streptomycin (Life Technologies) and 1% 
GlutaMAX (Life Technologies). Cells were passaged using standardized protocols with 0.25% 
trypsin-EDTA (Life Technologies) and maintained at conditions of 37°C with 5% CO2. Cells 
were encapsulated in GelMA matrices of varying densities by mixing 20μL of a stock cell 
solution containing approximately 3750 cells/μL with 130μL of 7%, 10%, or 15% GelMA pre-
polymer solution (w/v).  The cell/GelMA solution was pipetted drop-wise into 5mL of 
autoclaved vegetable oil and UV cured for 1 minute with an intensity of 5mW/cm2 using a 
Hamamatsu LED Controller (Hamamatsu C11924-511; Hamamatsu Photonics K.K., Japan), 
taking advantage of an oil emersion based surface tension technique for cell encapsulation (Fig. 
2.1A).[19] The solidified GelMA hydrogels containing encapsulated cells were then washed five 
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times with 5mL of sterile PBS, transferred into 2mL of supplemented DMEM, and cultured as 
previously reported.  Media was exchanged on each construct every 2 to 3 days until being fixed 
with 2% paraformaldehyde (Sigma) in PBS. 
 
2.3.3 Osteosarcoma mineralization 
 
Saos-2 cells were encapsulated and cultured as previously mentioned for specific durations of 
time before being chemically stimulated to produce mineral.  Specifically, Saos-2 cells were 
encapsulated at approximately 75,000 cells per construct and allowed to grow for either 7 days 
(for histological staining assays) or 2 weeks (for microCT) before being chemically stimulated 
with an induction media.  The induction media consisted of DMEM containing 10% FBS and 1% 
PSG supplemented with 0.1μM dexamethasone (Sigma Aldrich), 25 μg/mL L-ascorbic acid-2-
phosphate (AA2P; Sigma Aldrich), and an increasing regiment of β-glycerophosphate (BGP; 
Sigma Aldrich).[20]  The BGP regimen included one media change with 5mM BGP, followed by 
one media change with 10mM BGP, and all subsequent media changes containing 20mM BGP.  
Once the specific time points for each experiment were reached, the samples were fixed in a 2% 
paraformaldehyde solution and cryo-protected with a 30% sucrose solution for both micro-
computed tomography imaging and sectioning. 
 
2.3.4 Histochemical analysis, Live/Dead staining, and image processing 
 
All encapsulated samples were fixed in a 2% formaldehyde solution. Chemically stimulated 
samples were cryo-protected with a 30% sucrose solution in PBS for both micro-computed 
tomography imaging and sectioning, while non-stimulated samples were cryo-protected using a 
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14% ethylenediaminetetraacetic acid (EDTA; Sigma) and 30% sucrose solution in PBS.  
Samples to be sectioned were embedded in Tissue Freezing Medium Blue (TFMTM; Electron 
Microscopy Sciences), snap frozen using liquid nitrogen, and sectioned into 10μm slices using a 
Leica CM3050 cryostat (Leica Biosystems, Germany). Following sectioning, non-chemically 
stimulated samples to be stained for F-actin were treated with 0.1 M sodium citrate buffer 
solution pH 6.0, washed with PBS, and stained with Alexa Fluor 568 Phalloidin (1:100 dilution; 
Life Technologies). Nuclei were counterstained with 2.5 μg/mL 4’, 6-diamidino-2-phenylindole 
(DAPI; Life Technologies) in PBS. Following sectioning, all chemically stimulated samples to 
be analyzed for mineral were stained with 40mM alizarin red S pH 4.2 (Sigma Aldrich) and 
counterstained with 2.5 μg/mL DAPI in PBS. The viability of cells was analyzed using a 
Live/Dead assay. To evaluate cell viability, all three different types of hydrogels containing 
encapsulated cells were placed in media containing calcein-AM (1:2000 dilution; Life 
Technologies) and ethidium homodimer (1:500 dilution; Life Technologies) after 5 days of 
growth and incubated at 37°C for 1 hour. Raw .tiff images were taken for all sectioned samples 
using an epifluorescence equipped Nikon Eclipse E-400 microscope (Nikon Corporation).  All 
reported images were processed linearly for brightness and contrast using Adobe Photoshop CC 
2015 (Adobe Systems Inc.).  Once adjusted for brightness and contrast, images were converted 
to gray scale and subsequently overlaid to produce published images. 
 
2.3.5 Micro-computed tomography 
 
Chemically stimulated samples were fixed in a 2% formaldehyde solution and subsequently 
cryo-protected with a 30% sucrose solution for micro-computed tomography imaging and 
sectioning. A Scanco micro-CT 40 (Scanco Medical) was used to image and quantify mineral 
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formation in chemically stimulated samples.  Samples were placed in groups of 3 inside gauze 
packed micro-CT canisters and kept hydrated with 2% formaldehyde solution during imaging.  
Samples were imaged at a 16 μm isotropic voxel resolution (55 kV, 145 mA, 200 ms integration 
time). After scanning, mineralized tissue volume (bone volume, BV) and density (BMD) were 
calculated by applying a lower global threshold (166 mg HA/cm3) to the image, which was 
digitally contoured. 
 
2.3.6 Quantitative values and statistical analysis 
 
All quantitative values, with the exception of micro-computed tomography values, were obtained 
using open-source ImageJ (NIH) software.  Retrieved data was entered manually into Microsoft 
Excel (Microsoft Corporation) where values were reported as means ± standard deviation.  One-
way ANOVA was performed using Microsoft Excel data pack.  P-values < 0.05 were considered 
statistically significant. 
 
2.4 Results 
 
2.4.1 Formation of cell-laden hydrogels 
 
In order to determine how osteoblast-like cells behaved while encapsulated within a soft gelatin 
matrix, 75,000 Saos-2 cells were mixed with three different concentrations of GelMA 
prepolymer solution (7%, 10%, and 15% w/v), pipetted into an oil bath to form hydrated beads, 
and UV cured for one minute (Fig. 2.1A). Free radicals released from the photoinitiator (Irgacure 
2959) in the pre-polymer solution caused the covalent binding of acrylate groups during the UV 
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exposure, thereby crosslinking GelMA drops (~6mm x 6mm x 4mm) (Fig. 2.1B). This technique 
utilized the surface tension between aqueous GelMA solution and vegetable oil to crosslink 
GelMA drops at the air-GelMA-oil interface, and provided an easy-to-use approach with high 
degree of reproducibility.[19]  A relatively low seeding density was used in order to maximize 
cell-matrix interactions within the three different types of hydrogels and the volume of the drops 
was specifically chosen to mimic murine bone defects.   
 
Figure 2.1:  Cellular encapsulation schematic. (A) Schematic of surface tension encapsulation 
technique.  75,000 Saos-2 cells in 20 µl aliquots were combined with 130 µl of prepolymer 
solution containing .25% photoinitiator and pipetted dropwise into a bed of vegetable oil.  UV 
light was cast onto the hydrogel drops for one minute to cure before being rinsed with PBS and 
transferred into incubation media.  (B) Cured hydrogel spheres containing encapsulated cells 
resembled disc like structures with dimensions approaching 6mm x 6mm x 4mm (scale bar = 
5mm).  (C)  Mechanical data of various GelMA (w/v) concentrations modified from previous 
work.[18] 
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2.4.2 Viability of encapsulated cells 
 
The size of the hydrogel drop was designed to maximize cell-matrix interactions in a porous 
space that mimicked a murine bone defect.  Viability was quantified 5 days after encapsulation 
using ethidium homodimer (dead cells = red staining) versus calcein-AM (live cells = green 
staining) (Fig. 2.2A).  It was found that there was an apparent higher viability in the less dense 
7% hydrogels with approximately 60% live as opposed to only 40% live in both the 10% and 
15% gels.  However, due to inherent diffusion limitations in constructs many millimeters in size, 
low cell viability was observed. In order to determine how cells behaved within the hydrogel 
matrices at various stages of growth, histological sectioning was performed.  Accordingly, the 
GelMA drops were fixed in 2% paraformaldehyde and cryosectioned into 10 μm slices to allow 
for imaging.  A specific region of interest (ROI) was chosen to standardize measurements 
between samples (Fig. 2.2B).  The ROI used in all analysis was determined to be the area 
between the center of the sectioned slices and the corresponding slice periphery. 
 
Due to expected nutrient diffusion limitations within the denser hydrogels, it was necessary to 
quantify cell number in the sectioned ROIs at specific time points to determine cell migration 
patterns. To analyze whether cells were forming colonies inside the bulk material or simply 
migrating out of the constructs, cells were counted in the ROIs for each of the three types of 
hydrogels at 3 day, 7 day and 14 day timepoints by staining fixed slices with DAPI (nuclei) (Fig. 
2.2C Left).  More cells were counted, on average, in the ROIs of the 7% gels at all timepoints 
and decreased as the gels became denser.  For the 3 day time point, 19 cells on average were 
observed in the 7% constructs while only 12 cells were counted in the 15% constructs.  
Additionally, over time the number of cells within the ROI of the 7% gels increased at a higher 
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rate than those in the 15% gels, with 39 cells on average appearing in the 7% and only 17 cells 
appearing in the 15%.  This represented an approximately 100% increase in the amount of cells 
in the ROI of the 7% gel with only a 41% increase in the 15% gel.  
 
Cells encapsulated within GelMA spheres were transfected with GFP in order to determine 
spatial cell location inside the scaffolds prior to fixation, as well as inherent cellular activity at all 
stages of growth.  At each specified timepoint, fixed and sectioned samples were imaged for 
green emissions to ensure that counted cells were still active.  In addition to the standard 3 day, 7 
day, and 14 day time points, cells were imaged inside of the ROIs well over 1 month after the 
initial photocuring to show long term activity (Fig. 2.2C Right). 
 
As a result of GelMA autofluorescence when exposed to UV light after cell nuclei were stained 
with DAPI, construct degradation of all three types of hydrogels could be measured.  Constructs 
were fixed and stained with DAPI at 3 day, 14 day and 49 day time points in order to determine 
if a quantifiable relationship existed between bulk matrix degradation and hydrogel density (Fig. 
2.2D).  In general, the less dense hydrogels showed higher porosities (defined as void area 
fraction within a 10μm slice) than denser hydrogels at all time points.  Compared to the dense 
15% hydrogels, 7% gels were 4% more porous at 3 days, 7% more porous at 14 days and 16% 
more porous at 49 days.  Additionally, it was shown that denser gels degraded slower over time, 
with 7% gels increasing in porosity by 21% from 3 to 49 days, compared to an 11% increase in 
10% gels and a 9% increase in 15% gels.  
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Figure 2.2:  Cellular viability and activity within degradable hydrogel scaffolds of different 
stiffness.  (A) Cells were grown within hydrogel constructs for 5 days and analyzed for cellular 
viability using calcein-AM (live = green) and ethidium homodimer (dead = red).  Fluorescent 
images of live/dead cells show live and dead cells throughout the entire scaffold.  (B) 
Representative schematic of the region of interest used to standardize measurements between 
fixed and sectioned histological samples.  Areas between the center of the slices and the 
peripheries were used due to sectioning artifacts.  (C) Cells stained with DAPI were counted in 
the ROI of histological slices for 3 day, 7 day, and 14 day timepoints.  Increases in cellular 
population over time within the hydrogels were evident in all samples at all timepoints (n = 3; * 
= p < 0.05).  (C) Saos-2 cells tagged with green fluorescent protein (GFP) appeared in all 
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samples well over one month after encapsulation (scale bar = 100μm).  (D) Fluorescence in 
histological samples due to DAPI staining allowed for apparent porosity of hydrogels containing 
encapsulated cells to be measured for 3 day, 14 day and 49 day timepoints.  Blue coloring 
represents GelMA staining while black coloring represents apparent void space.  All gels 
degraded significantly over time (n = 3; * = p < 0.05; scale bar = 100μm). 
 
2.4.3 Cellular morphology 
 
In addition to showing cell migratory differences throughout the three different hydrogel 
constructs, cell morphology was cataloged at different time points to determine if matrix density 
had an effect on cellular growth. Cell morphology was determined in the ROI for each of the 
three types of gels at 3 day, 7 day, and 14 day time-points by staining fixed construct slices with 
DAPI (nuclei) and phalloidin (F-actin).  At early timepoints, cell morphology appeared similar in 
the 7%, 10% and 15% gels, but changed dramatically at the later timepoints.  At later timepoints, 
cells within the ROI in the less dense gels formed large, defined clusters while cells in the 10% 
and 15% gels formed either limited or no clusters.  Representative images of each type of 
construct indicate significant differences between cellular aggregations and morphology between 
the 7%, 10%, and 15% samples (Fig. 2.3A Top).  This observation is evident in the high-
resolution photographs at the 14D timepoint (Fig. 2.3A Bottom).   
 
The aggregate nucleus diameter and area of encapsulated cells, as well as the aggregate lacunae 
diameter and area of encapsulated cells, were quantified in order to highlight the differences 
between how cell colonies grew within the bulk matrix of the three different hydrogels (Fig. 
2.3B). The aggregate area and diameter of nuclei stained with DAPI were rather consistent for all 
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different gels at each of the three timepoints, except for numerous large clusters of nuclei that 
were predominately observed in the 7% gels after 14 days of culture.  Synonymously, the 
aggregate lacunae area and diameter were similar in all scaffolds at each stage of growth except 
for the large clusters of cells that formed intricate lacunae after 14 days in the soft 7% gels. 
 
Figure 2.3:  Nuclear and cytoskeleton staining of encapsulated Saos-2 cells.  (A) Cells were 
grown within hydrogel constructs for either 3, 7, or 14 days, fixed, sectioned, and stained for f-
actin (red = phalloidin) and counterstained for nuclei (blue = DAPI).  Representative pictures at 
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7 days (scale bar = 100μm) and 14 days (high resolution; scale bar = 20μm) show distinct 
morphological differences in the ROI of samples of different densities at all timepoints.  (B) 
Histological samples stained with phalloidin and counterstained with DAPI were analyzed for 
morphological differences in the nuclei and lacunae at 3 day, 7 day, and 14 day timepoints.  
Measurements showed significant differences in aggregate nuclear diameters and areas, as well 
as aggregate lacunae diameters and areas, for softer hydrogels over time (n = 3; * = p < 0.05). 
 
2.4.4 Mineral deposition 
 
To better examine the potential effects of matrix stiffness on osteogenesis, Alizarin red S 
staining was used to identify the presence of deposited calcium in chemically stimulated 
hydrogels. Cells were stimulated to produce mineral 7 days after encapsulation and were 
subsequently grown for an additional 2 weeks in osteogenic media in order to determine what 
effect hydrogel density had on bone nodule formation.  Alizarin red and DAPI counterstain were 
used to visualize fixed samples for mineral (Fig. 2.4A), and mineral content and mineral area 
within the ROI was quantified (Fig. 2.4C).  Consistent with previous results, the total area 
fraction of mineral within the ROI was greater by 3-fold in the ROI of 7% gels than in the dense 
15% gels, while mineral clusters in the ROI of less-dense hydrogels had areas 3.5-fold greater 
than those in 15% gels. 
 
A different group of samples were grown for 2 weeks in order to mimic the 14-day culture 
period used in the cellular morphology studies and were subsequently stimulated in osteogenic 
media for an additional 14 days.  After four weeks, samples were fixed and scanned via microCT 
to determine total bone mineral content (Fig. 2.4B, C).   7% hydrogels showed indiscrete mineral 
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formation throughout the entire construct while 15% gels showed concentrated mineral 
formation at the peripheries.  Total mineral content appeared to be similar in both the 7% and 
15% samples with 0.053 mg HA and 0.058 mg HA respectively. 
 
Figure 2.4:  Mineralization and microCT of encapsulated Saos-2 cells.  (A) Cells were grown 
within hydrogel constructs for 7 days and were subsequently placed in osteogenic media for an 
additional 14 days.  Constructs were fixed, sectioned, stained for mineral deposition (red = 
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alizarin red S) and counterstained for nuclei (blue = DAPI).  Representative pictures for all 
samples show distinct difference in the mineral located within the ROI for different gel densities 
(top scale bar = 100μm; bottom scale bar = 20μm).  (B) Cells were grown within hydrogel 
constructs for 14 days and were subsequently placed in osteogenic media for an additional 14 
days.  Samples were analyzed via microCT for total mineral within the constructs of different 
stiffnesses.  (C) Histological samples stained with alizarin red S and counterstained with DAPI 
were analyzed for mineral cluster area and area fraction of mineral coverage within the ROI and 
showed significant differences for hydrogels of varying density (n = 2; * = p < 0.05).  MicroCT 
scans were analyzed for total mineral throughout the constructs and showed no significant 
differences between hydrogels of varying density (n = 3). 
 
2.5 Discussion 
 
As compared to conventional studies performed on non-physiological 2-D substrates, Saos-2-
laden GelMA hydrogels provide a more realistic 3-D environment with which to study bone 
regeneration.[21, 22]  Although human osteosarcoma Saos-2 cells do not completely represent 
the response of primary human osteoblasts, Saos-2 do serve as a robust, model cell line capable 
of allowing for the assessment of the biocompatibility and differentiating potential of the GelMA 
matrix.  As such, the results from this work indicate that the density of GelMA plays a vital role 
in encapsulated cell viability, morphology, and function.  
 
UV crosslinking of photopolymers have several advantages over both chemical and ionic 
(physical) crosslinking strategies.  UV crosslinking allows for easy tuning of material properties, 
eliminates the need for organic solvents, and provides short reaction times.  One recent study 
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reported the encapsulation of human mesenchymal stem cells within a synthetic hydrogel 
containing Irgacure 2959 photoinitiator and demonstrated excellent cellular viability 14 days 
after UV crosslinking for varying curing times.[23]  Specifically, UV light (100 W/365 nm) was 
exposed to hMSC-laden hydrogels for times varying between 2.5 minutes and 10 minutes, and 
DNA damage was not detected when exposure time was kept around 2.5 minutes. Other studies, 
which used similar UV crosslinking techniques for 2-3 minutes, also demonstrated no significant 
changes or damage to the cells as a result of UV exposure.[24]  In our study, we only use an 
exposure time of 1 minute, much lower than the reported times causing observable DNA 
damage. 
 
Recent work with UV-crosslinkable hydrogels containing living cells has shown success in an in 
vivo setting.  Specifically, N-methacryloyl chitosan hydrogels mixed with living cells was 
demonstrated to undergo rapid transdermal crosslinking in vivo within 60 s through minimally 
invasive clinical surgery.  Histological analysis revealed that low-dose UV irradiation did not 
induce skin injury and the acute inflammatory response disappeared after only 7 days.[25]  
Another study showed that encapsulated bone marrow-derived mesenchymal stem cells in UV 
crosslinked GelMA hydrogels demonstrated enhanced osteogenesis in vivo with significant 
mineralization.[26]  In yet another study, GelMA hydrogels containing multipotent stromal cells 
within an ectopic rat model was used to engineer endochondral bone.[27] 
 
As mentioned previously, low cellular viability of encapsulated osteosarcomas was expected 
since cells are required to be within 200-300μm of a nutrient supply in order to properly function 
in vivo.  Due to the larger size of our cell-laden hydrogels and inherent diffusion limitations 
associated with dense constructs, viabilities ranging from 40 to 60 percent were normal.  In a 
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similar study, Saos-2 cells were encapsulated within sodium-alginate drops of only 1mm in 
diameter and were found to survive at higher rates as compared to the GelMA drops used in this 
study, further emphasizing the role media diffusion plays in maintaining high levels of cellular 
viability.[28] 
 
The observed cell count differences in the ROIs of the three different gels suggested that cells 
were migrating outside of the denser constructs due to poor nutrient diffusion.  This result was in 
line with a recent study where it was shown that the cellular viability of encapsulated 
mesenchymal stem cells (MSCs) inside the matrix of porous gelatin constructs increased as 
porosity increased.[29]  Additionally, the observation that cells within the ROIs of the more 
porous matrices were able to form larger clusters further suggested that cells within the less 
dense gels remained active in the bulk material while cells in the dense gels migrated towards the 
peripheries.  Furthermore, the ability of cells within the 7% and 10% hydrogels to form defined 
cell colonies was consistent with existing literature detailing how cells behave while 
encapsulated in soft material. One recent study used sub-millimeter sized beads to encapsulate 
MG-63 osteosarcoma cells within gelatin-modified alginate (AlGel) hydrogels[30] and showed 
that the clusters of cells that formed within the AlGel had several protrusions with lengths of 
approximately 30μm extending between colonies. Similar phenomena have also been observed 
within encapsulated hematopoetic stem cells[31] and human embryonic stem cells.[32] 
 
In this work, we used GelMA, a collagen derivative, as our soft component since it has tailorable 
mechanical properties, is able to be chemically modified with various peptides, is biodegradable, 
and has crosslinked environments similar to the natural extracellular matrix (ECM). Although 
dense GelMA matrices showed less mineralization near the center of the construct, cells were 
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still metabolically active and capable of surviving.  Additionally, since there were no significant 
differences between the amounts of mineral produced in the 7% constructs versus the 15% 
constructs, it could be suggested that the encapsulated cells in the denser scaffolds migrated 
towards the periphery in order to uniformly encase the structure.  Furthermore, although the 
levels of BGP used in the osteogenic media far exceeded reported physiological levels[33, 34], 
indiscriminate mineralization was not observed in acellular controls, suggesting that all mineral 
observed was cell mediated.  Based on these observations, it is plausible to suggest that properly 
vascularized hydrogels of increased density could encourage osteogenic cells to create mineral in 
a consistent, ordered fashion.    
 
2.6 Conclusions 
 
This work showcases the advantages of using a gelatin-based porous hydrogel for bone tissue 
engineering.  By understanding how the osteoblast-like cells function within hydrogels of 
different densities, it may be possible to capitalize on this knowledge and design more complex 
structures capable of directed bone formation.  Specifically, going forward the denser hydrogels 
used in this study will be the base material for future work due to the robust mineral formation at 
the hydrogel peripheries. 
 
2.7 Non-Author Acknowledgements 
  
We would like to thank Shihao Yang for his assistance in synthesizing GelMA macromer and 
analyzing data, as well as Sean DeBoyace for his help in culturing cells.  This work was 
	 49	
supported by the Soft Interfaces Integrative Graduate Education and Research Traineeship 
(IGERT) at Syracuse University and funded by the National Science Foundation (NSF).  
 
2.8 Disclosure statement   
 
There are no competing financial interests pertaining to this work. 
 
2.9 References 
 
1. Sawyer, S., et al., Behavior of encapsulated saos-2 cells within gelatin methacrylate 
hydrogels. J Tissue Sci Eng, 2016. 7(173): p. 2. 
2. Liu, Y., J. Lim, and S.-H. Teoh, Review: development of clinically relevant scaffolds for 
vascularised bone tissue engineering. Biotechnology Advances, 2013. 31(5): p. 688-705. 
3. Amini, A.R., C.T. Laurencin, and S.P. Nukavarapu, Bone tissue engineering: recent 
advances and challenges. Critical Reviews™ in Biomedical Engineering, 2012. 40(5). 
4. Eastlack, R.K., et al., Osteocel Plus Cellular Allograft in Anterior Cervical Discectomy 
and Fusion: Evaluation of Clinical and Radiographic Outcomes From a Prospective 
Multicenter Study. Spine, 2014. 39(22): p. E1331-E1337. 
5. Deyo, R.A., et al., Use of bone morphogenetic proteins in spinal fusion surgery for older 
adults with lumbar stenosis: trends, complications, repeat surgery, and charges. Spine, 
2012. 37(3): p. 222. 
6. Griffith, L.G. and G. Naughton, Tissue Engineering--Current Challenges and Expanding 
Opportunities. Science, 2002. 295(5557): p. 1009-1014. 
	 50	
7. Loh, Q.L. and C. Choong, Three-dimensional scaffolds for tissue engineering 
applications: Role of porosity and pore size. Tissue Engineering Part B: Reviews, 2013. 
19(6): p. 485-502. 
8. Burg, K.J., S. Porter, and J.F. Kellam, Biomaterial developments for bone tissue 
engineering. Biomaterials, 2000. 21(23): p. 2347-2359. 
9. Reichert, J.C. and D.W. Hutmacher, Bone tissue engineering, in Tissue Engineering. 
2011, Springer. p. 431-456. 
10. Bose, S., S. Vahabzadeh, and A. Bandyopadhyay, Bone tissue engineering using 3D 
printing. Materials Today, 2013. 16(12): p. 496-504. 
11. Stevens, M.M., Biomaterials for bone tissue engineering. Materials Today, 2008. 11(5): p. 
18-25. 
12. Hutmacher, D.W., Scaffold design and fabrication technologies for engineering tissues—
state of the art and future perspectives. Journal of Biomaterials Science, Polymer Edition, 
2001. 12(1): p. 107-124. 
13. Annabi, N., et al., 25th Anniversary Article: Rational design and applications of 
hydrogels in regenerative medicine. Advanced Materials, 2014. 26(1): p. 85-124. 
14. Schuurman, W., et al., Gelatin‐Methacrylamide Hydrogels as Potential Biomaterials for 
Fabrication of Tissue‐Engineered Cartilage Constructs. Macromolecular Bioscience, 
2013. 13(5): p. 551-561. 
15. Lewis, K.J. and K.S. Anseth, Hydrogel scaffolds to study cell biology in four dimensions. 
MRS Bulletin, 2013. 38(03): p. 260-268. 
16. Peppas, N.A., et al., Hydrogels in biology and medicine: from molecular principles to 
bionanotechnology. Advanced Materials, 2006. 18(11): p. 1345-1360. 
	 51	
17. Wu, Y., et al., Fabrication of conductive gelatin methacrylate–polyaniline hydrogels. 
Acta Biomaterialia, 2016. 33: p. 122-130. 
18. Chen, Y.X., et al., A Novel Suspended Hydrogel Membrane Platform for Cell Culture. 
Journal of Nanotechnology in Engineering and Medicine, 2015. 6(2): p. 021002. 
19. Pradhan, S., C.S. Chaudhury, and E.A. Lipke, Dual-phase, surface tension-based 
fabrication method for generation of tumor millibeads. Langmuir, 2014. 30(13): p. 3817-
3825. 
20. Thakur, N.A., S.D. DeBoyace, and B.S. Margulies, Antagonism of the Met5‐enkephalin‐
opioid growth factor receptor‐signaling axis promotes MSC to differentiate into 
osteoblasts. Journal of Orthopaedic Research, 2015. 34(7): p. 1195-1205. 
21. Saldaña, L., et al., In search of representative models of human bone-forming cells for 
cytocompatibility studies. Acta Biomaterialia, 2011. 7(12): p. 4210-4221. 
22. Ayobian-Markazi, N., T. Fourootan, and M.J. Kharazifar, Comparison of cell viability 
and morphology of a human osteoblastlike cell line (SaOS-2) seeded on various bone 
substitute materials: An in vitro study. Dental Research Journal, 2012. 9(1). 
23. Kumar, D., et al., Three-dimensional hypoxic culture of human mesenchymal stem cells 
encapsulated in a photocurable, biodegradable polymer hydrogel: a potential injectable 
cellular product for nucleus pulposus regeneration. Acta Biomaterialia, 2014. 10(8): p. 
3463-3474. 
24. Chung, C., et al., Influence of gel properties on neocartilage formation by auricular 
chondrocytes photoencapsulated in hyaluronic acid networks. Journal of Biomedical 
Materials Research Part A, 2006. 77(3): p. 518-525. 
	 52	
25. Li, B., et al., Hydrosoluble, UV-crosslinkable and injectable chitosan for patterned cell-
laden microgel and rapid transdermal curing hydrogel in vivo. Acta Biomaterialia, 2015. 
22: p. 59-69. 
26. Zhao, X., et al., Injectable Stem Cell‐Laden Photocrosslinkable Microspheres Fabricated 
Using Microfluidics for Rapid Generation of Osteogenic Tissue Constructs. Advanced 
Functional Materials, 2016. 26(17): p. 2809-2819. 
27. Visser, J., et al., Endochondral bone formation in gelatin methacrylamide hydrogel with 
embedded cartilage-derived matrix particles. Biomaterials, 2015. 37: p. 174-182. 
28. Schloßmacher, U., et al., Alginate/silica composite hydrogel as a potential 
morphogenetically active scaffold for three-dimensional tissue engineering. RSC 
Advances, 2013. 3(28): p. 11185-11194. 
29. Wang, L., et al., Fabrication of Cell-Laden Macroporous Biodegradable Hydrogels with 
Tunable Porosities and Pore Sizes. Tissue Engineering Part C: Methods, 2014. 21(3): p. 
263-273. 
30. Grigore, A., et al., Behavior of encapsulated MG-63 cells in RGD and gelatine-modified 
alginate hydrogels. Tissue Engineering Part A, 2014. 20(15-16): p. 2140-2150. 
31. Yuan, Y., et al., Ex vivo amplification of human hematopoietic stem and progenitor cells 
in an alginate three‐dimensional culture system. International Journal of Laboratory 
Hematology, 2011. 33(5): p. 516-525. 
32. Chayosumrit, M., B. Tuch, and K. Sidhu, Alginate microcapsule for propagation and 
directed differentiation of hESCs to definitive endoderm. Biomaterials, 2010. 31(3): p. 
505-514. 
33. Boyan, B., et al., Osteoblast-mediated mineral deposition in culture is dependent on 
surface microtopography. Calcified Tissue International, 2002. 71(6): p. 519-529. 
	 53	
34. Bonewald, L., et al., von Kossa staining alone is not sufficient to confirm that 
mineralization in vitro represents bone formation. Calcified Tissue International, 2003. 
72(5): p. 537-547. 
 
 
 54 
CHAPTER 3:  DEVELOPING 3D SCAFFOLDS IN THE FIELD OF TISSUE 
ENGINEERING TO TREAT COMPLEX BONE DEFECTSD*[1] 
 
3.1 Abstract 
 
Polymers have been extensively used to develop 3D scaffolds in the field of tissue engineering 
and consist of certain design requirements such as biocompatibility, structural properties, and 
varying porosity inside of complex geometries, all with the ultimate goal of incorporating living 
cells within the scaffold structure. In this work, we present the synthesis and material 
characterization of hybrid spools using polycaprolactone (PCL) as the base polymer. We 
demonstrate that a commercial 3D Fused Deposition Modelling printer such as Makerbot can be 
used to print 3D scaffolds using three types of polymer spools: PCL, PCL-poly lactic acid (PLA) 
and PCL-hydroxyapatite (HA). Data derived from computerized tomography can be used to 
develop hollow porous cages using PCL. Lastly, we demonstrate that log-pile scaffolds are 
capable of being infused with a mixture of living cells and gelatin hydrogel.  This work could be 
potentially useful in the treatment of patients with complex bone defects. 
                                                        
D Adapted from:  Albrecht LD, Sawyer SW, Soman P.  (2016) Developing 3D scaffolds in the field of tissue engineering to treat 
complex bone defects.  3D Printing and Additive Manufacturing 3(2):106-12. 
* Reprinted as permitted by Mary Ann Liebert, Inc. author agreement for personal reuse. 
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3.2 Introduction 
 
Bone has emerged as the second most transplanted tissue in the world as a result of patient 
traumas, aging populations, osteoporosis, and bone tumors.[2] Since current clinical therapies 
have not been sufficiently successful, the field of bone tissue engineering continues to develop 
new bone substitutes by combining porous biomaterial scaffolds with relevant cells, growth 
factors and other stimuli.  Important aspects of bone tissue engineering include the fabrication of 
porous polymer scaffolds with patient-specific geometries, the necessary structural strength to 
house living cells, and the ability to facilitate tissue ingrowth during in vitro development of 
bone tissue or during in vivo implantation.[3-7]  
 
To promote cell proliferation, tissue growth, and remodeling, porous scaffolds have been 
developed using several different manufacturing approaches. Use of traditional fabrication 
methods such as solvent casting, freeze drying, porogen leaching, fiber bonding, dual phase 
separation, and gas foaming typically create simple geometries and only allow limited control 
over pore-interconnectivity within 3D scaffolds, both of which are extremely essential for bone 
tissue applications.[8-10] With the goal of developing scaffolds with a 100% pore-
interconnectivity, additive manufacturing and other solid free form fabrication (SFF) techniques 
such as laser sintering[11], stereolithography[12], and Fused Deposition Modelling (FDM) [4, 
13] have been used.[6, 7] Several researchers have developed manufacturing equipment based on 
FDM principles where a polymer spool is extruded through a heated nozzle and can subsequently 
be moved using commands obtained from a computer-aided manufacturing program.[13, 14]  
 
While most labs have typically developed custom made extrusion-based equipment to print user-
defined 3D scaffolds, the emergence of easy-to-use commercial 3D printers have allowed other 
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researchers with non-manufacturing backgrounds to print complex 3D models. For example, 
physicians use Makerbot printers to develop anatomically accurate physical models for 
educational purposes and practice surgeries. The drawback, however, is that these physical 
models can be only built using commercially available and easy-to-use polymer spools. Certain 
types of biomaterial spools such as polycaprolactone (PCL), a thermoplastic commonly used for 
bone tissue engineering applications,[15] are not commercially available and have to be custom-
made in research labs. Furthermore, these direct-writing techniques that rely on the properties of 
non-commercial colloidal biomaterial inks capable of being printed as droplets, hot-melts, or 
continuous filament lines [16-20] need specialized manufacturing knowledge to operate them. 
Moreover, incorporation of living cells within 3D printed scaffolds is yet another significant 
challenge and cells seeded on scaffolds with small pore-sizes could result in uneven cellular 
distribution throughout the scaffold. 
 
In this work we demonstrate the synthesis and fabrication of 3D scaffolds using hybrid 
polycaprolactone (PCL) spools using an easy-to-use commercial Makerbot 3D printer. Hybrid 
spools were developed by mixing commercially available fillers such as poly-l-lactic-acid (PLA) 
or hydroxyapatite (HA) particles within the PCL matrix, following which mechanical and 
materials properties were characterized. We also demonstrate the incorporation of living cells 
into the interior of the log-pile scaffold with a facile and easy-to-use technique.  
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3.3 Materials and Methods 
 
3.3.1 Development of hybrid spools 
 
Spools were made using a Randcastle microfilament extruder (Randcastle Inc.) and a base 
material of polycaprolactone (PCL) pellets having a 3mm diameter and 70kDa-90kDa molecular 
weight (Sigma Aldrich) (Fig. 3.1A). The raw PCL material and the fillers, either hydroxyapatite 
(HA) (Sigma Aldrich) or poly-l-lactic-acid (PLA) were mixed and fed into the extruder hopper. 
The shear force of the machine’s extrusion screw fed the raw material (PCL) and filler (either 
PLA or HA) into the four heating zones, allowing for homogenization of PCL-PLA composites 
and mixing of PCL-HA composites.  A cooling zone was located below the third heating zone 
and the thread of the screw was reversed, thereby causing a buildup of pressure that forced the 
melted polymer mixture out of the head (heating zone 4). The temperatures were kept at 160° 
Fahrenheit (72° Celsius), just above 140° Fahrenheit (F) or 60° Celsius (C), which was the 
melting point for PCL, for the pure PCL spool in order to keep the polymer in liquid state during 
the extrusion process and maintain constant pressure. For the PCL-HA spool the temperatures 
were raised to 170°F (76.6°C) in order to allow HA powder to mix with liquid PCL, and for the 
PCL-PLA spool the temperatures were raised to 320°F (160°C) in order to melt both of the 
polymers since PLA has a melting point between 300°-320°F. The pressure for each spool was 
kept at 1000 psi +/- 200 psi and fed through a custom nozzle with an opening diameter of 
1.57mm. The filament expanded once it left the extruder head to the appropriate 1.75 +/- 
0.05mm so that it could be wound into spools and fed into the commercially available 3D printer, 
Makerbot Replicator 2 (Makerbot Industries) (Fig. 3.1B).  
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3.3.2 Chemical composition and testing 
 
To determine the final material composition post extrusion and printing, a high resolution 
thermogravimetric analysis (TGA) was performed on PCL, PCL-HA and PCL-PLA samples 
using a Q500 thermogravimetric analysis (TA Instruments). The TGA heated spool samples to 
and beyond their degradation points while weighing them so that the amounts of each 
polymer/component could be determined based on weight percentages.  
 
3.3.3 3D printing and mechanical testing 
 
Spools were loaded into the Makerbot and both Solidworks (Dassult Systems) and Meshmixer 
(Autodesk) were used to generate the .stl files used to make the g-code for the printed scaffolds. 
Solidworks was used to make the log-pile geometry with two different sizes: (1) 10.5mm x 
10.5mm x 12mm, and (2) 6mm3, both containing sufficient porosities that allowed for repeatable 
and mechanically reliable prints. In addition to log-pile scaffolds, two complex geometries were 
fabricated using a computerized tomography (CT) scan of a right femur. The scans were 
converted to .stl files and added to Meshmixer, a program that allows for unique customization 
of .stl files in order to make user-specified designs that could be printed reliably.  
 
To test the mechanical strength of the scaffolds, the larger log-pile structures (Fig. 3.1) were 
placed between two plates on a compression MTS machine (Sintech 2 G) with a 10K Newton 
load cell. The samples were compressed to failure and the machine recorded the downward cross 
head travel and the force from the load cell. 
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3.3.4 Cell incorporation within log-pile scaffolds 
 
A mixture of gelatin methacrylate (GelMA) mixed with human osteosarcoma cells (Saos-2) were 
incorporated within log-pile scaffolds. Using a previously reported protocol GelMA was 
synthesized.[21, 22]   Briefly, porcine skin gelatin was mixed at 10% (w/v) in phosphate 
buffered saline (PBS, Thermo Fisher Scientific) and stirred at 45oC until dissolved.  After the 
porcine skin gelatin was dissolved, methacrylic anhydride was added to the solution and stirred 
at the same temperature for 3 hours.  After stirring, the solution was dialyzed against distilled 
water for seven days at 40˚C, freeze-dried, and stored at -80°C until needed. For cell 
encapsulation experiments, a final GelMA prepolymer solution of 7% was prepared by mixing 
freeze-dried GelMA with PBS and 0.25% UV photoinitiator Irgacure 2959 (Specialty Chemicals, 
Switzerland) at room temperature. 
 
Human osteosarcoma cells (Saos-2) were purchased from American Type Culture Collection 
(ATCC) and cultured in Dulbecco’s Modification of Eagle’s Media (DMEM; Life Technologies) 
supplemented with 10% fetal bovine serum (v/v) (FBS lot K14133; Atlanta Biological), 1% 
penicillin-streptomycin (Life Technologies) and 1% GlutaMAX (Life Technologies).  Cells were 
passaged using 0.25% trypsin-EDTA (Life Technologies) and maintained at 37°C. A mixture of 
GelMA and Saos-2 cells was created by adding 20μL of a cell solution containing approximately 
5000 cells/μL to 130μL of GelMA prepolymer solution.  Cell/GelMA solution was pipetted 
dropwise onto sterilized PCL, PCL/PLA, and PCL/HA scaffolds and subsequently crosslinked 
using a Hamamatsu LED Controller (Hamamatsu C11924-511; Hamamatsu Photonics K.K., 
Japan).  Viability of cells were analyzed using a Live/Dead assay on day 5. To evaluate cell 
viability, scaffolds were placed in media containing calcein-AM (1:2000 dilution; Life 
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Technologies) and ethidium homodimer (1:500 dilution; Life Technologies) and incubated at 
37°C for 1 hour.  After 1 hour, scaffolds were cut into three equal pieces using single edge 
industrial razor blades and imaged using an epifluorescence microscope (Nikon, Eclipse E-400, 
Nikon Corporation, Japan). Raw .tiff images were taken for all samples and processed linearly 
for contrast and brightness using Adobe Photoshop CC 2015 (Adobe Systems Inc., CA).  
Processed images were overlaid and false colored to create final live/dead images with green 
representing live cells and red representing dead cells.  Brightfield images were not processed 
linearly for contrast and brightness. Images were also obtained using Hirox KH-8700 digital 
microscope (Hirox-USA, Inc., NJ). 
 
3.4 Results 
 
3.4.1 3D printing using hybrid PCL spools 
 
The overall process of manufacturing log-pile geometries using hybrid spools is depicted in 
Figure 1.  In order to manufacture spools, a Randcastle microfilament extruder was used to 
combine base PCL material with either HA or PLA (Fig. 3.1A).  Extruded filaments of an 
appropriate diameter of 1.75±.05mm could then be wound and fed into a commercially available 
Makerbot Replicator 2 3D printer (Fig. 3.1B). 
 
A range of process parameters used for 3D printing (Fig. 3.1C) were determined from the 
melting point and degradation point information for each spool that were obtained from 
thermogravimetric analysis. A set of temperatures were chosen within these ranges and 
optimized such that the spools could be fed into the machine in a reliable and repeatable manner. 
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Temperature, which was the critical variable, was adjusted to allow easy printability (extrusion) 
using viscous melts.  
 
For clarity, the “diameter” variable does not refer to the diameter of the spool, but rather to a 
number fed into Makerbot Slicer program.  This was necessary to compensate the pushing force 
on various spools. For PCL and PCL-HA spools, this variable was decreased from 1.75mm 
(standard size) to 1.5mm in order to force the extruder to push more filament out, effectively 
compensating for the differences in density from PLA (1.4g/cm3) to PCL (1.14g/cm3).   Finalized 
log-pile prints were realized after optimizing the printing conditions (Fig. 3.1D). 
 
Figure 3.1:  3D printing schematic using hybrid PCL spools.  (A) The raw material is fed into 
the filament extruder creating a long strand of three polymer spools (PCL, PCL-HA, and PCL-
PLA).  (B) A commercially available MakerBot Replicator 3D printer.  (C) The printer settings 
are set for each filament spool, respectively.  (D) The model of the log-pile scaffolds and the 
printed counterparts to the right.  Scale bar:  2mm.  HA, hydroxyapatite; PCL, polycaprolactone; 
PLA, polylactic acid.   
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3.4.2 Composition and mechanical properties of printed scaffolds 
 
High-resolution thermogravimetric analysis (Fig. 3.2A) was used to quantify the exact amount of 
filler (PLA or HA) in the PCL matrix. The sample was heated above its degradation point and 
the derivative of the heat of the furnace (the rate of heating) was measured as it related to the 
drop in weight of the test-sample. This analysis was used primarily to demonstrate two distinct 
degradation points and a % composition of hybrid samples (Fig. 3.2A, B). Both PCL and PCL-
HA had a degradation point of 383°C and the change weight between PCL and PCL-HA 
(15.81%) was representative of the weight of HA present in PCL-HA spool, as inorganic HA 
does not degrade and remains on the balance after complete degradation of the PCL component. 
The actual amount of HA was found to be slightly lower after thermogravimetric analysis than 
was present during the spool-making process (15.81% as compared to 20%).   
 
Similarly, the amount of PLA was found to be slightly lower after analysis.  The mixture of PCL 
and PLA had two distinct degradation points (the first degradation point for PLA being at 325°C 
and the second point for PCL being at 355°C)  which were used as markers for determining the 
percentage of each constituent in the combined spool (Fig. 3.2B). From the thermogravimetric 
analysis, the exact amount of PLA in PCL matrix was determined to be 47.7%, a minor deviation 
from the 50:50 ratio initially put into the extrusion hopper 
 
Mechanical properties for log-pile scaffolds were obtained from the stress-strain curves using a  
MTS machine (Fig. 3.2B, C, D). PCL-PLA, PCL-HA and PCL had average compressive 
strength of 159.2 MPa, 59.3 MPa and 44.3 MPa respectively (n=5). The increase in moduli in the 
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hybrid PCL-PLA spools was a result of the higher moduli of pure PLA filler added to the PCL 
matrix.  
 
Figure 3.2:  Printed scaffold compositions and mechanical properties.  (A) High-resolution 
TGA of polymer spools.  (B) Results in tabular form showing the degradation points and 
percentages for each compound.  (C) Compression testing apparatus to obtain mechanical 
properties of log-pile scaffolds.  (D) Stress-strain plots and bar graphs of modulus and maximum 
stresses for each polymer spool (n=5).  TGA, thermogravimetric analysis. 
 
3.4.3 3D printing of complex porous geometries 
 
PCL is a common biopolymer used for bone tissue engineering applications and its ability to be 
readily augmented and printed in specific shapes via commercial 3D printers could lead to 
enhanced clinical solutions for bone defects.  Custom scaffolds for bone repair are able to be 
printed from Cartesian data obtained from a CT scan, allowing the possibility of patient-specific 
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support cages for bone tissue engineering (Fig. 3.3). The first geometry shown was created in 
order to have a log-pile lattice similar to the log-pile geometry described earlier and was 
modified from the .stl file of a human femur (Fig. 3.3A). A scaled femur model was placed into 
the mesh program and sliced in order to obtain a small cross section of the diaphysis. The 
Meshmixer program was then used to render the model into various different layers while 
keeping the same external geometry (Fig. 3.3B, red outline). The lattice structure was used to 
maximize the internal free space while minimizing the amount of material used to support 
reliable printing of the structure.  
 
To increase the internal free space, another type of scaffold was developed using Voronoi 
analysis, a solution which only uses the surface data in the .stl file (Fig. 3.3C). The Voronoi was 
made by reducing the number of triangles on the surface of the .stl file and subsequently using 
the Dual Edges function to give them all a tubular thickness and density.   For each filament, the 
.stl files were uploaded into the Makerbot Desktop software and the settings were edited in the 
slicing program to obtain printing repeatability. The resulting hollow cages maintained the 
external geometry as derived from the CT scan, while still leaving space for the incorporation of 
biomaterials containing living cells. 
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Figure 3.3:  3D printing of complex geometries.  (A) Cartesian data for a human femur were 
placed into the MakerBot Desktop.  (B) A slice from the diaphysis of the femur was taken and 
Lattice meshed in Meshmixer.  On the right is the 3D printed model in PCL.  (C) Longer slice 
from the diaphysis was Voronoi meshed in Meshmixer to create a hollow cage-like 
representation of the outside femur.  On the right is the 3D printed PCL model. 
 
3.4.4 Cell incorporation within log-pile scaffold 
 
To visually model a process in which live cells could be contained within a 3D printed log-pile 
structure, a 6mm3 PCL log-pile scaffold was placed inside a rectangular chamber and 
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subsequently covered with 7% GelMA containing 15% (v/v) MiO orange coloring (Kraft Foods 
Inc., IL) (Fig. 3.4A).  The GelMA was pipetted drop-wise onto the PCL scaffolds and 
simultaneously solidified using UV light exposure.  Sliced sections from the top, middle, and 
bottom areas were successfully able to show a thorough incorporation of GelMA within in the 
interiors of the log-pile scaffold (Fig. 3.4B).  As reported, the infusion process was facilitated by 
using a plastic column containing a small outlet port in the bottom of the chamber, thereby 
allowing an even flow-through of GelMA solution throughout the entire scaffold.   
 
For cell encapsulation, a mixture of gelatin methacrylate (7% GelMA) and human osteosarcoma 
cells (5000 cells/μL; Saos-2) were incorporated within a PCL-PLA log-pile structure in a similar 
manner. After day 5, the log-pile structure was incubated with calcein-AM and ethidium 
homodimer and imaged fluorescently for live/dead analysis (Fig. 3.4C).  Live cells (green) were 
shown in the top, middle and bottom sections of the sliced log-pile scaffold. 
 
Figure 3.4:  Incorporation of cells within 3D printed scaffolds.  (A) Schematic representation 
of the process used for incorporating living cells within printed scaffolds.  The case was slightly 
larger than the 6mm3 log-pile structure to allow for GelMA-cell solution perfusion.  (B) PCL 
scaffold infused with 7% GelMA containing 15% (v/v) MiO orange coloring to show complete 
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infusion of GelMA throughout the scaffold (left to right: PCL GelMA top, PCL GelMA middle, 
PCL GelMA bottom).  (C) Live (green)/Dead (red) calcein-AM/ethidium homodimer pictures 
from PCL/PLA scaffold (left to right:  PCL-PLA GelMA top, PCL-PLA GelMA middle, PCL-
PLA GelMA bottom).  GelMA, gelatin methacrylate. 
 
3.5 Discussion 
 
We chose PCL as our base material due to its extensive use in developing scaffolds for bone 
tissue engineering. PCL is a semi-crystalline aliphatic polymer with suitable rheological 
properties such as glass transition temperature and melting point, and is readily biodegradable by 
hydrolysis.[23]  HA, while a major component of native bone that has been shown to promote 
bone mineralization, is difficult to machine due to its brittle characteristics.[24, 25] 
 
One significant challenge in creating the composite spools was the difficulties in achieving 
filaments of consistent diameter (1.75mm), a necessary requirement for several commercially 
available 3D printers. This was achieved by controlling the extruder-pressure and barrel screw 
revolution, and by varying the “suckback” variable on MakerBot (Fig. 3.1C). The “suckback” is 
typically set at 1.3mm at a velocity of 25mm/s in order to break off each extrusion. Since PCL 
has a high specific heat, “suckback” was set to zero to avoid blocking the printer nozzle. 
 
A second challenge that will need to be addressed in subsequent studies is the apparent loss of 
both HA and PLA in the spool manufacturing process (Fig. 3.2B).  As previously mentioned, 
there was a slight decrease in the amount of HA (15.81% as compared to 20%) and PLA 
(47.70% as compared to 50%) measured in the composite PCL-HA and PCL-PLA spools as 
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compared the starting materials placed into the hopper.  While the exact cause of the loss is 
unknown, it is most likely attributed to the adhesion of HA and PLA to either the inner barrel of 
the extruder or any of the other various surfaces that they came in contact with throughout the 
manufacturing steps.  
 
Natural bone is an organic/inorganic composite typically consisting of cortical and cancellous 
bone[26] with a compressive strength ranging from 131-205 MPa and a Young’s Modulus 
ranging between 10 – 20 GPa.[27, 28]  As reported here, the compressive strength of the hybrid 
spools had moduli ranging from 59-159MPa, thereby falling within the target zone required for 
bone tissue engineering.  However, as the compressive strengths of the spools were on the low 
end of that of natural bone, more work would be needed to replicate the properties of natural 
bone. 
 
Model scaffolds used for bone tissue engineering should mimic both the mechanical and 
chemical composition of natural bone.  Since natural bone contains collagen fibers,[26] we 
decided to incorporate GelMA laden with living cells into the printed log-pile scaffolds. We 
chose GelMA, a denatured form of collagen, as the model hydrogel because it contains an 
abundance of biologically active cell-adhesion motifs, has highly controllable mechanical 
properties, and provides increased transparency for imaging.[29]  Human Saos-2 cells were 
chosen in this study due to the fact that they are a robust cell line that can be used in the initial 
stages of new bone defect models.  By choosing Saos-2 for our initial work, we were able to 
limit donor dependent differences that would arise from primary cells.  In the future, we plan to 
use bone marrow derived stem cells to obtain an understanding of how scaffold design 
parameters influence the cell number and their metabolic activities. Integration of the structural 
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cage with cell-laden GelMA showed a construct compatible with the multifunctional nature of 
bone and showcased the potential for a tissue engineering model capable of improving the 
handling characteristics of soft hydrogel constructs under weight bearing conditions. The open 
frame design provided sufficient space for cell-laden hydrogels to support bone mineralization, 
remodeling, and integration with host tissues, while at the same time providing an interface that 
could possibly integrate with host tissues.  
  
3.6 Conclusion 
 
Polymers, with their favorable processing properties, have been extensively used to develop 3D 
scaffolds for tissue engineering applications. 3D printing of tissue engineering scaffolds often 
requires customized instruments such as heated extruders and computer controlled XYZ stages 
with precisely coordinated movements in order to lend themselves properly in the creation of 
biopolymer properties (viscosity, melting temperature, printing speed). This project developed 
hybrid spools with PCL polymer as the base material as well as hybrid spools readily compatible 
with commercial 3D printers such as the MakerBot. Porous geometries were printed using CT 
scan data with both internal log-pile lattice structures as well external meshed structures.  
Finally, we demonstrated that living cells mixed in gelatin hydrogels could be incorporated 
within log-pile scaffolds with high initial cellular viability.  
 
Moving forward, while it was shown that cell-laden GelMA could be incorporated between the 
struts of PCL and PCL composites, the varying viability of the cells in the center and bottom of 
the log-pile scaffolds indicates that an inherent porosity is needed for the proper delivery of 
nutrients to the encapsulated cells.  Additionally, as it was shown that the compressive strength 
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of the PCL and PCL cages were less than pure thermoplastic PLA cages alone, future work in the 
manufacturing of a structurally supported cell-laden hydrogel will utilize pure thermoplastic 
cages instead of PCL composites. 
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CHAPTER 4:  PERFUSION DIRECTED 3D MINERAL FORMATION WITHIN CELL-
LADEN HYDROGELSD*[1] 
 
4.1 Abstract 
 
Despite the promise of stem cell engineering and the new advances in bioprinting technologies, 
one of the major challenges in the manufacturing of large-scale bone tissue scaffolds is the inability 
to perfuse nutrients throughout thick constructs. Here, we report a scalable method to create 
perfusable bone constructs using a combination of cell-laden hydrogels and a 3D printed sacrificial 
polymer. Osteoblast-like Saos-2 cells were encapsulated within a gelatin methacrylate (GelMA) 
hydrogel and 3D printed polyvinyl alcohol (PVA) pipes were used to create perfusable channels. 
A custom-built bioreactor was used to perfuse osteogenic media directly through the channels in 
order to induce mineral deposition which was subsequently quantified via microCT.  Histological 
staining was used to verify mineral deposition around the perfused channels, while COMSOL 
modeling was used to simulate oxygen diffusion between adjacent channels.  This information was 
used to design a scaled-up construct containing a 3D array of perfusable channels within cell-laden 
GelMA.  Progressive matrix mineralization was observed by cells surrounding perfused channels 
as opposed to surface mineral deposition in static constructs.  MicroCT confirmed that there was 
a direct relationship between channel mineralization within perfused constructs and time within 
the bioreactor.   
																																																													
D Adapted from:  Sawyer SW, Shridhar SV, Zhang K, Albrecht LD, Filip AB, Horton JA, Soman P.  (2018) Perfusion directed 3D 
mineral formation within cell-laden hydrogels.  Biofabrication 10(3). 
* Reprinted with permission from IOP Publishing with minor editing provisions. 
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4.2 Introduction 
 
One of the largest barriers to engineering a large-scale bone tissue replacement is the ability to 
supply essential nutrients throughout the entire construct.  Since hypoxia and necrosis occur to 
cells that lie outside of the natural diffusion range of 200–300 μm, proper vasculature must be 
available within the replacement tissue to ensure graft viability.[2-4]  In traditional static culture 
systems, nutrient diffusion, and therefore mineralization and cellular viability, is limited to the 
outer 200-300 μm of the construct while deeper regions of the system remain hypoxic.[5, 6]   
 
In an attempt to increase nutrient diffusion into engineered scaffolds, a variety of means such as 
solvent casting, particulate leaching, phase separation, gas foaming, emulsion freeze drying, and 
fiber meshes have been used to generate a wide range of porous scaffolds.[7-10]  While these 
particular methods have been shown to enhance mass transfer within the machined constructs as 
well as improve cell seeding, cell proliferation, and construct mineralization, they unfortunately 
have not provided a complete solution.  In particular, these methods do not easily provide the 
precise control over pore parameters needed for larger tissue constructs and can often result in 
inhomogeneous cellular densities and outcome measures that are hard to predict. Furthermore, 
since these methods often require harsh solvents and high temperatures, incorporating live cells 
during fabrication is near impossible.[10-12]  Alternatively, the encapsulation of osteogenic cells 
within biocompatible hydrogel bioinks such as collagen, alginate, and gelatin can allow for a 
uniform and controlled distribution of cells in situ.[13-20] However, the absence of macroporous 
voids in the cell-laden hydrogel constructs present similar nutrient diffusion limitations.[4]  
Additionally, although the cell friendly hydrogel provides an environment which is able to closely 
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mimic the natural extracellular matrix, their weak mechanical stability provides yet another 
obstacle for their use in bone tissue engineering.  
 
Recently, 3D printing technologies have enabled the creation of user-defined channels within cell-
laden hydrogels through the extrusion of bioinks in a layer-by-layer manner alongside co-printed 
sacrificial materials.[21-28] Post-print, the sacrificial material is removed via non-toxic means, 
resulting in user defined channels within bulk gels.  However, methods such as this require custom-
made bioprinters with specialized control hardware and software as well as tunable viscoelastic 
bioinks that must be specifically matched with the printing parameters.  While perfusion of these 
constructs with nutrients is possible, the systems used are difficult to scale.  
 
A simpler, and readily scalable, fabrication method is one that combines the casting of cell-laden 
hydrogels around pre-fabricated 3D printed structures containing sacrificial materials.  In this 
work, we utilize an unmodified, commercially available 3D printer and water soluble sacrificial 
material (PVA) to establish perfusable channels within the center of a diffusion limited, 
structurally supported GelMA hydrogel laden with osteoblast-like cells. The construct is designed 
to have one inlet and one outlet that provides a direct interface between the cell-laden GelMA and 
perfusion of nutrients via a scalable, pump-driven bioreactor system. The simple horizontal 
channel geometry provides a robust method with which to analyze the influence of long-term 
(4week) perfusion of osteogenic media on the viability and function of encapsulated cells. 
Additionally, COMSOL modeling of oxygen diffusion is used to determine optimal spacing 
between adjacent 3D printed channels, allowing for the design to be scaled up into a perfusable, 5 
pipe array.  
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4.3 Materials and Methods 
 
4.3.1 3D printing of frames and pipes 
 
Acrylonitrile butadiene styrene (ABS) thermoplastic frames with inner dimensions of 9mm long 
x 6mm wide x 3mm deep containing 1mm holes along the construct peripheries and sacrificial 
polyvinyl alcohol (PVA, 400μm diameter) pipes were printed using a commercially available 
MakerBot Replicator 2 3D printer (MakerBot) (Fig. 4.1A).  PVA pipes were UV sterilized for 24 
hours and ABS frames were sterilized via submersion in 70% EtOH for 24 hours.  
 
4.3.2 Design and fabrication of polycarbonate bioreactor  
 
Polycarbonate bioreactors were machined from clear, autoclavable, scratch and UV resistant 
polycarbonate sheets (McMaster-Carr) (Fig. 4.1 D-F).  Briefly, pre-milled polycarbonate blanks 
were machined in a MT300 Pro CNC Milling Center (AutoMateCNC) to create both the bottom 
bioreactor base and its corresponding top plate (Fig. S4.1-2). The bottom bioreactor base plate 
contained four wells approximately 13mm long x 9mm wide x 3mm deep surrounded by 10 screw 
holes machined using a #43 drill bit.  Vertical holes for perfusion along the periphery of the base 
plate were machined using a #52 (outer) and #72 (inner) drill bit for 21G needle (Thermo Fisher 
Scientific) insertion.  Top plates contained screw holes machined using a #34 drill bit.  To ensure 
a water-tight seal between the polycarbonate base and top, a polydimethylsiloxane gasket (PDMS, 
Ellsworth Adhesives) mixed in a 1:4 ratio was cured at 60oC for 24 hours and inserted between 
the base and top sections.  
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4.3.3 Gelatin methacrylate (GelMA) synthesis 
 
20% (w/v) gelatin methacrylate (GelMA) prepolymer solution used for cellular encapsulation was 
synthesized according to our previous work.[29]  Briefly, porcine skin gelatin (Sigma Aldrich) 
was mixed at 10% (w/v) in phosphate buffered saline (PBS, Thermo Fisher Scientific) and reacted 
with methacrylic anhydride (Sigma Aldrich).  After dialysis and lyophilization, GelMA macromer 
was stored at -80°C until needed. Prior to cellular encapsulation, GelMA macromer was combined 
with PBS and 0.25% UV photo-initiator Irgacure 2959 (Specialty Chemicals) to form the 
prepolymer solution and sterile filtered using a 0.20 µm filter (Corning).   
 
4.3.4 Cell culture and perfusion setup 
 
Human osteosarcoma cells (Saos-2, ATCC), which can be used to represent the early stages of 
osteogenesis,[30] were chosen as osteoblast analogues for our model system.  Dulbecco’s 
Modification of Eagle’s Media (DMEM, Life Technologies) supplemented with 1% Glutamax 
(Life Technologies), 1% penicillin-streptomycin (Life Technologies), and 10% fetal bovine serum 
(FBS lot G12102, Atlanta Biologicals) was used as the base media for Saos-2 culture.  Cells were 
maintained at 37°C in a humidified, 5% CO2 atmosphere and passaged prior to any new experiment.  
In order to chemically induce Saos-2 cells to produce mineral, the base media was supplemented 
with 100 μM L-ascorbic acid-2-phosphate (AA2P, Sigma-Aldrich), 5mM b-glycerophosphate 
(BGP, Sigma-Aldrich), and 10 nM dexamethasone (DEX, Sigma-Aldrich). 
 
Prior to in situ polymerization, approximately 1x106 cells were suspended in 20% (w/v) GelMA 
to create a 15% (w/v) solution (162 µl final volume), and transferred to the 3D printed hybrid ABS 
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frame/PVA pipe construct via dropwise pipetting (Fig. 4.1B).  After the construct was filled, the 
cell-GelMA solution was UV cured for 1 minute 20 seconds at approximately 5 mW/cm2 via a 
Hamamatsu LED Controller (Hamamatsu C11924-51; Hamamatsu Photonics K.K., Japan).  PVA 
pipes were eluted from the constructs by incubation for 24 hours in warmed media (Fig. 4.1C).  
Constructs destined for static culture conditions remained in 12-well culture dishes, with media 
renewed every 2-3 days. Constructs destined for perfusion conditions were transferred and press 
fit within the polycarbonate bioreactor base (Fig. 4.1D-E). Construct perfusion was maintained 
using a syringe pump system (NE-300 Just InfusionTM, New Era) at 0.2 μl/hr per well, for up to 
28 days (Fig. 4.1F).  Syringes were replaced as needed during the course of the experiments. 
 
4.3.5 Cellular viability 
 
Cell viability of encapsulated Saos-2 cells was evaluated using a Live/Dead assay for two time 
points: 1 day after encapsulation and 14 days after either perfusion or static culture using 
osteogenic media.  Samples to be evaluated were sliced into 1mm thick sections and transferred 
into culture media supplemented with calcein-AM (live, 1:2000 dilution, Life Technologies) and 
ethidium homodimer (dead, 1:500 dilution, Life Technologies) for one hour prior to imaging.  
 
4.3.6 MicroCT analysis 
 
Constructs were removed from the bioreactor intact, fixed in formaldehyde (4% for 24 hours), 
washed in PBS, and placed lengthwise in a 16 mm diameter sample holder for micro-CT imaging 
(micro-CT 40, Scanco Medical AG, Brüttisellen, Switzerland). Foam spacers were placed between 
samples, which were kept hydrated with PBS. Samples were imaged at a 16-20 μm isotropic voxel 
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resolution (55 kV, 145 mA, 200 ms integration time). After scanning, mineralized tissue volume 
(bone volume, BV) and density (BMD) were calculated by applying a lower global threshold (166 
mg HA/cm3) to the image, which was digitally contoured to isolate the entire length of the 
perfusion channel from the bulk construct mass (Fig. S4.3). Thickness of the mineralized matrix 
surrounding the perfusion channel was calculated using the 2D section morphology tool in 
BoneJ.[31] Briefly, the reconstructed micro-CT images (.isq files) were imported into ImageJ, 
cropped to isolate the perfusion channel, and a global threshold of 166 mg HA/cm3 was applied 
prior to running BoneJ. The BoneJ plugin then calculates an average “cortical thickness” for each 
image slice, which corresponds to mineral wall thickness in this model.  Consistency in 
thresholding between ImageJ and Scanco software was ensured by importing a scan of the Scanco 
hydroxyapatite (HA) quality control phantom into ImageJ, and plotting greyscale (ImageJ) values 
vs. HA density.  However, based on the fact that the structural organization and chemical 
constitution of the deposited mineral cannot be verified via micro-CT, the cell-mediated deposition 
is referred to as “mineral” in the subsequent text. 
 
4.3.7 Histological analysis 
 
Perfused samples were prepared for histological analysis via standard snap freezing protocols.  
Briefly, samples were fixed in 4% formaldehyde for 24 hours before treatment with a 30% sucrose 
in PBS solution for 48 hours.  After sucrose treatment, samples were embedded in Tissue Freezing 
Medium (Electron Microscopy Sciences) and frozen over dry ice.  Sections (10µm thick) were cut 
on a Leica CM3050 cryostat (Leica Biosystems, Germany) and mounted on lysine coated 
SuperFrost Plus slides.  Cover-slipped and stained sections were imaged using a Nikon Eclipse E-
400 microscope (Nikon Corporation). 
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Hematoxylin and Eosin (H&E) Staining: Sections were stained by standard H&E procedure using 
Mayer’s Hematoxylin and Eosin/Phloxine solutions (Electron Microscopy Sciences). Sections 
were then dehydrated through an ethanol series, cleared in xylene, and cover-slipped with 
Permount (Fisher Scientific) for imaging.  Imaged sections were analyzed via ImageJ (NIH) for 
cell quantification. 
 
Alizarin Red S Staining:  Calcium mineral deposition was visualized using 40mM Alizarin Red S 
solution (4.1 pH, Sigma). After staining for 5 minutes, slides were washed in deionized water and 
mounted and imaged as previously described. 
 
Image J Box Plot Analysis: H&E images were imported into ImageJ and analyzed via a box 
analysis for cell quantification.  Briefly, images were converted to binary via automatic 
thresholding and values representing cells were recorded in boxed increments of 325 μm2 away 
from the edge of the channel lumen.  For each image, three different directions were analyzed 
away from the central channel. 
4.3.8 COMSOL modeling 
 
COMSOL was first used to model oxygen diffusion within cell-laden GelMA constructs between 
adjacent channels spaced 1mm apart (edge-to-edge). Two domains were considered. Domain 1 
represented the primary flow of nutrients supplied from the inlet reservoir and was solved using 
Navier-Stokes steady state flow analysis. Domain 2 represented the diffusion of media and 
consumption by cells, and was solved by diffusion-consumption analysis using Michaelis–Menten 
rate laws.  The “Reacting Flow of Porous Media” module in COMSOL was used to plot steady 
state oxygen diffusion within cell-laden GelMA. The GelMA matrix was represented via user-
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defined material values of porosity (0.5)[32], and permeability (1 x 10-7)[33].  The maximum 
amount of dissolvable oxygen was assumed to be 0.2185 [mol.m-3][34], approximately 
representing oxygen dissolved in water. The consumption of oxygen by cells was represented as a 
decrease in oxygen species over time, following the equation, R = -kt, where R is the reaction rate 
(R<0), k is the rate constant relating to oxygen concentration, and t is time in [s]. The rate constant 
was determined to be 2 x 10-5 [mol.s-1] by taking into account the oxygen consumption rate of cells 
within each GelMA construct.[35]   
 
COMSOL was also used to model the changes in oxygen diffusion within cell-laden GelMA 
constructs due to mineral deposition around the lumen/channels. In this model, three domains were 
considered.  Domain 1 represented the primary flow of nutrients supplied from the inlet reservoir 
and Domain 2 represented the diffusion of media and consumption by cells encapsulated within 
GelMA. A new Domain 3 was introduced in the form of a donut-shell and represented both regions 
of mineral deposition and cell-laden GelMA. With more perfusion time, the thickness of Domain 
3 increased and the porosity decreased due to an increasing amount of mineral deposition. The 
thickness of the donut-shell Domain 3 was obtained from Image J data, while the material porosity 
of Domain 3 (𝑃"#$%&'()*++) at weeks 1, 2, and 4 was calculated as described below. The porosity 
of Domain 3 was a combination of (i) the porosity of the mineralized GelMA (identified from CT 
data) and (ii) the porosity of cell-laden GelMA (identified as void regions in CT data) given by the 
following equation (Fig. 4.6B-C): 
𝑃"#$%&'()*++ 	= 		𝐴 ∗ 𝑃12$*34+ + (1 − 𝐴) ∗ 𝑃9*+:;   
where A is the fraction of the donut-shell area occupied by mineralized GelMA and (1-A) is the 
remaining fraction that is occupied by cell-laden GelMA. Porosity of pure bone, 𝑃12$*34+ (0.035) 
and cell-laden GelMA 𝑃9*+:; (0.5) were obtained from previously published work[32, 36]. In this 
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work, the inner channel radius was assumed to be 0.2 mm while the outer donut-shell radius for 
weeks 1, 2 and 4 were calculated as 0.2719 mm, 0.2854 mm and 0.2873 mm respectively from the 
Bone J cortical thickness measurements of the mineralized crust.  𝐴, the fraction of donut shell 
area occupied by the mineral, was calculated via a two-step process.  First, CT data was imported 
into MIMICS (Materialise, Belgium), a medical image processing software program, and 30 
surface slices were generated for each time point and converted into 2D masks before being 
exported into Image J as binary (.stl) files. Second, the freehand boundary option in Image J was 
used to mark the irregular outer boundaries in each image to calculate the area occupied by mineral 
and void regions (area occupied by cell-laden GelMA).  This data was then used to calculate 
𝑃"#$%&'()*++ for week 1, 2 and 4 (Fig. 4.6D). 
 
4.3.9 Statistical analysis 
 
Numerical data was entered into Microsoft Excel to calculate mean and standard deviation and 
either Student’s t-test or one-way ANOVA was used to assess statistical significance of differences.  
P-values less than 0.05 were accepted as statistically significant. 
 
4.4 Results 
 
4.4.1 Design and fabrication of a plug-and-flow construct 
 
Mechanically supportive ABS cages capable of housing GelMA hydrogels were printed using a 
commercially available 3D printer.  Sacrificial polyvinyl alcohol (PVA) pipes were printed and 
inserted into holes within the ABS cage peripheries (white, Fig. 4.1A, B). GelMA prepolymer was 
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cast into the constructs and UV cured (Fig. 4.1B, C) prior to the dissolution of the pipes (Fig. 
4.1C). A fully customizable, two-piece plug-and-flow bioreactor fitted with a PDMS gasket was 
used to house the 3D printed constructs (Fig. 4.1D-F, S4.1-2).  Within the bioreactor base, the 3D 
printed constructs containing GelMA hydrogels could be press fit and perfused with DI water 
containing an orange food dye via a standard syringe pump.  Flowed wells containing no constructs 
showed fluid-tight seals (Fig. 4.1E middle-top) while the well containing an ABS cage and 
GelMA hydrogel with dissolved pipe showed directed dye flow (Fig. 4.1E bottom).   
 
All aspects of the plug-and-flow model process were capable of being fully sterilized using 
conventional techniques.  Specifically, the PVA pipes and bioreactors were UV sterilized for 24 
hours prior to use and the ABS frames were sterilized in 70% EtOH.  Accordingly, the system was 
capable of being placed within a standard cell culture incubator for extended periods of time (Fig. 
4.1F).  Nutrients needed for cell viability were perfused through the constructs via a syringe pump 
placed within the incubator and gas exchange took place through a pressure relief needle in the 
waste collection area. 
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Figure 4.1:  Design and performance testing of 3D-printed construct and bioreactor 
apparatus.  Schematic and representative images of the mechanically supportive ABS frame with 
inserted pipe before (A) and after (B) photopolymerization of GelMA, and after dissolution of the 
sacrificial PVA pipe (C).  Schematic image of a two-piece polycarbonate bioreactor containing a 
PDMS gasket between layers (D) and leakage test of polycarbonate bioreactor showing liquid-
tight seal in machined device (E).  Complete bioreactor setup inside a standard cell culture 
incubator (F).   
 
4.4.2 Perfusable GelMA hydrogels containing Saos-2 cells 
 
In order to create cell-laden GelMA hydrogels containing encapsulated cells and fully perfusable 
pipes, Saos-2 cells were added to GelMA prepolymer and cast into the constructs.  After curing, 
constructs were placed in cell culture media for 24 hours prior to being placed in either well plates 
for static culture or the bioreactor for perfusion with osteogenic media (Fig. 4.2A). To determine 
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if the plug-and-flow bioreactor represented a viable cell culture platform, cells were encapsulated 
around the dissolvable pipes and cultured for 24 hours in order to determine process associated 
cell death.  After one day of culture, minimal cell death was observed around the dissolved pipe 
(red, Fig. 4.2B).  Constructs perfused with osteogenic media for two weeks showed high cell 
viability (green, Fig. 4.2C) and mineral deposition around the entirety of the pipe (Fig. 4.2D).  
MicroCT imaging showed mineral deposition surrounding the channel along the entire length of 
the construct (Fig. 4.2E).  
 
Control experiments were run with cell-laden GelMA constructs without channels. Cells were 
encapsulated within ABS cages containing no dissolvable pipes and incubated for either 1 day or 
14 days in osteogenic media (Fig. 4.2F).  After 1 day of culture constructs were sectioned into 
1mm slices and showed low cell viability in the center of the hydrogel (red, Fig. 4.2G).  After 14 
days of static culture high cell death, in addition to a decreased number of cells, was observed (Fig. 
4.2H) and no mineral appeared to form in the center of the hydrogel (Fig. 4.2I, J). 
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Figure 4.2:  Perfusion can direct mineral deposition.  Schematic representation of outcomes 
following osteogenic induction under (A) perfusion or (F) static culture conditions. Cell viability 
by fluorescent live (green)/dead (red) staining after perfusion (B, C) or static culture (G, H) 
conditions for either 1 (B, G) or 14 days (C, H) respectively. Brightfield microscopy showed an 
accumulation of an opaque matrix surrounding the perfused pipe (D) that was not evident in static 
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constructs lacking a pipe (I) (scale bar: 400µm). Micro-CT imaging demonstrated mineral deposits 
surrounding the perfused pipe (E), whereas mineral accumulated only at the periphery of 
constructs maintained in static conditions (J).  
 
4.4.3 Channel mineralization and modeling 
 
MicroCT was used to evaluate mineral formation around the construct channels under both static 
and dynamic conditions. Samples cultured within the bioreactor and perfused with osteogenic 
media for either 1 (P-W1), 2 (P-W2), or 4 (P-W4) weeks showed robust mineralization along the 
channel walls (Fig. 4.3A, Right). Solid samples containing no channels in static osteogenic culture 
showed mineral deposition around the construct periphery with no quantifiable activity within the 
center of the construct (Fig. 4.2J).  Under the same conditions, constructs with channels were 
cultured in static osteogenic conditions for either 1 (S-W1), 2 (S-W2), or 4 (S-W4) weeks and 
showed increasing amounts of mineral deposition along the central pipe walls (Fig. 4.3A, Left).  
Additionally, in the static culture mineral was also deposited on the surface of the constructs, but 
appeared random and unordered.  Furthermore, acellular control experiments showed no presence 
of mineral, indicating that the mineralization was completely mediated by encapsulated Saos-2 
cells. 
 
For mineral quantification, only the central channels of the constructs were digitally contoured in 
order to normalize comparisons between static and perfused samples (Fig. S4.3).  Quantification 
of micro-CT data for the central channels of each construct showed that after one month of either 
static or perfusion culture, mineralization of the inner lumens increased significantly both 
volumetrically and in total mineral content for the 4 week samples as compared to their 1 and 2 
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week counterparts (Fig. 4.3B, S4.4). Additionally, perfused constructs did not have significantly 
more mineral around their inner lumens as compared to their static equivalents.  Furthermore, 
despite the increase in mineral content, the density of mineral formed was consistent among all 
samples at all time points, regardless of culture type (Fig. 4.3C). 
 
To further characterize the constructs perfused within the bioreactor, BoneJ was used to analyze 
the micro-CT data to determine the average thickness of the mineral ring formed around the central 
channels (Fig. 4.6D, Table). While an upward trend in thickness could be inferred based on the 
data available, there was no statistically significant change as a function of time. Additionally, 
although total mineral content did increase significantly over the course of 4 weeks for the perfused 
samples, the high variability in data, as well as the fact that the total mineral formed was not 
significantly greater in the perfused samples as compared to their static counterparts (Fig. S4.4), 
suggested that an increasing crust thickness could be inhibiting diffusion into the surrounding 
hydrogel matrix.  
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Figure 4.3:  MicroCT analysis of mineral deposition.  Representative microCT image of total 
mineral deposition after culture in osteogenic media under static (S) or perfused (P) conditions for 
1, 2, or 4 weeks (A).  For representative images, the entire frame was digitally contoured in order 
to visually show how mineralization occurs in static samples immersed in osteogenic media versus 
samples perfused directly with osteogenic media.  Mineral volume deposited around pipes after 1, 
2, or 4 weeks of both static osteogenic culture and osteogenic media perfusion showed significant 
increases in volume after 4 weeks (4wk static and 4wk flow n=7, 2wk flow n=8, rest n=6.  * p<0.05 
via one-way ANOVA) (B).  Density of mineral deposited around pipe after 1, 2, or 4 weeks of 
both static osteogenic culture and osteogenic media perfusion remained constant at every time 
point (4wk static and 4wk flow n=7, 2wk flow n=8, rest n=6) (C). 
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4.4.4 Histological analysis and quantification 
 
Alizarin red S staining was used to visualize whether the diffusion limitations affected 
mineralization away from the perfused pipes, as well as verify that the deposits observed by the 
micro-CT contained calcium.  After one week of perfusion, a small amount of mineral was present 
away from the pipe (Fig. 4.4 A, P-W1).  After two weeks of perfusion, an increase of mineral was 
observed away from the perfused lumen, but appeared to decrease to levels consistent with 1 week 
of flow as the distance increased towards the construct peripheries (Fig. 4.4A, P-W2). After 4 
weeks of perfusion, however, while the amount of mineral observed closest to the pipe did not 
appear to increase significantly, more robust staining was observed (Fig. 4.4A, P-W-4).  
Additionally, a significant amount of mineral was detected further away from the pipe in the 4 
week samples as compared to both the 1 and 2 week samples, indicating that hydrogel degradation 
may possibly have played a role in the ability of the Saos-2 cells to mineralize the matrix after 4 
weeks of perfusion. 
 
H&E staining was performed on the perfused samples to visualize differences in construct 
cellularity over time (Fig. 4.4B) and a histogram analysis was used to quantify what effect long 
term diffusion had on the distribution of cells away from the channel lumen (Fig. 4.4C,D).  After 
one week of perfusion, a large number of cells were observed approximately 300μm away from 
the channel, a distance in accordance with diffusion limitation values as reported in the literature 
(Fig. 4.4B,D).[37]  However, as the mineral crust increased over the course of 2 weeks to 1 month, 
the quantity of cells dropped significantly 300μm away from the pipe. 
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Figure 4.4:  Histological analysis of perfused constructs.  Cellular localization decreases, and 
matrix mineralization increases as function of distance from the perfused channels. Representative 
Alizarin Red (A) and H&E (B) histology stains of construct samples after either 1, 2, or 4 weeks 
of perfusion with osteogenic media (scale bar: 500µm).  Box plot analysis of H&E samples was 
used to measure cell number in measured increments away from the central pipe (scale bar: 325µm) 
(C).  Histogram quantification of the number of cells as a function of distance away from the lumen 
for 1, 2 and 4 week perfused samples shows that cell number decreases as the distance from the 
perfused channel increases (n=3, *p<0.05 via one-way ANOVA) (D). 
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4.4.5 Construct scalability 
 
To test the scalability of this plug-and-flow approach, an array of 5 dissolvable PVA pipes 
within a larger ABS construct (11x8x6 mm outer dimension; 6x6x6 mm inner dimension) was 3D 
printed. The optimal pipe spacing in the larger construct was chosen based on COMSOL 
simulations of the radial consumption of oxygen around the channels within the cell-laden GelMA 
matrix (Fig. 4.5A, B).  Specifically, COMSOL simulations showed that the addition of a second 
pipe spaced 1mm away would ensure that the lowest oxygen concentration anywhere between the 
pipes would be approximately 80%, as opposed to 50% and below with only one channel (Fig. 
4.5A-C).  Additionally, the design criteria were chosen to allow for the uncured cell-laden GelMA 
to conformably flow between the pipes, thereby ensuring there were no air pockets left between 
the pipes after UV exposure. Based on the analysis, it was determined that 400µm channels spaced 
approximately 1mm apart (edge-to-edge) would ensure that the entire hydrogel matrix between 
the channels would be adequately supplied with oxygen and other diffusible nutrients (Fig. 4.5C, 
D). 
 
The pipes were placed in three layers spaced 1mm apart in any direction (Fig. 4.5D) and the larger 
construct contained two reservoirs to ensure that all 5 pipes could be perfused via one syringe 
pump (Fig. 4.5E).  In order to flow media through the larger system, the original bioreactor design 
was increased only in the z-direction to highlight the ease of scaling (Fig. 4.5F).  After 4 weeks of 
perfusion, micro-CT and alizarin red S staining showed robust  mineral deposition along the length 
of each pipe, as well as between the pipes and along the edges of the bulk construct (Fig. 4.5 G-
I).  
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Figure 4.5:  Schematic representing the scalability of perfusable constructs.  Multiple 
channels spaced at optimal distances are capable of being perfused via one inlet (A).  COMSOL 
modeling of oxygen diffusion between one channel (B Top) and two channels spaced 1mm apart 
(B Bottom), as well as COMSOL modeling of the oxygen consumption as a function of radius by 
cells around the channels within cell laden constructs spaced 1mm apart (C) was used to determine 
optimal pipe spacing in larger constructs.  Schematic of a scaled cell-laden construct (D) and 
corresponding ABS cage (6x6x6 mm3) (E).  CAD isometric view of a machined, two-piece 
polycarbonate bioreactor containing a PDMS gasket between layers (red) (F).  Micro-CT imaging 
of mineral deposition surrounding pipes (G, side view; H, end view) after four weeks of perfusion 
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with osteogenic media showed that the model system could be easily scaled.  Representative 
Alizarin Red histology of a large-scale construct after perfusion with osteogenic media for 4 weeks 
showed robust mineralization (I) (scale bar: 500µm).   
 
4.4.6 Estimation of the influence of mineral formation on oxygen diffusion 
 
Based on the microCT results, it was clear that the mineral deposited by the encapsulated cells 
around the channel was not uniform (Fig. 4.6A). The annular ring of mineralized crust (Fig. 4.6B-
C) was porous with several void spaces that contained cell-laden GelMA. To gain insight into the 
spatial changes in oxygen diffusion due to the deposited mineralized “donut shell” around the 
channels, a new COMSOL Domain 3 (Fig. 4.6C) was introduced in the form of a “donut-shell” 
with thickness values obtained from Bone J data, and material porosity (𝑃"#$%&'()*++) values 
calculated as described in the Methods section (Fig. 4.6D). The results were plotted as percent 
decrease in oxygen concentration radially away from the channel/lumen edge (Fig. 4.6E).  The 
results demonstrate that a higher drop in oxygen concentration is possibly due to the formation of 
mineral. 
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Figure 4.6: Effect of mineral formation on oxygen diffusion radially across the channel. 
Surface slices were obtained from 3D data sets in MIMICS, and mineral area was measured (A-
B). A schematic model showing the three domains used for COMSOL modeling (C).  Table shows 
the various parameters used to calculate Domain 3 (D, Top table).  Simulation of oxygen diffusion 
for weeks 1, 2 and 4 (D, Bottom) (white arrows showing the donut shell thickness).  Distribution 
of oxygen radially away from the channel surface for weeks 1, 2 and 4 along with control without 
any mineral deposits (E).  
 
4.5 Discussion 
  
Provision of adequate vascular perfusion is one of the most daunting challenges facing the 
implantation of any tissue engineered construct.[38, 39] Accordingly, over the past decade 
numerous groups have successfully combined various techniques and sacrificial materials such as 
pluronics, 3D printed carbohydrates, and 3D printed gels to create vascularized systems, but in 
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each case the process used was extremely specific to the application being studied.[21, 40, 41]  In 
our plug-and-flow system, however, any component can be readily exchanged and scaled based 
on the desired application.  For instance, the model cell could be replaced with any other osteogenic 
cell such as patient-derived multipotent marrow stromal cells or autologous osteoblasts.  
Alternatively, the printed hydrogel could be easily modified via the addition of side groups and 
growth factors, or could be substituted for a different hydrogel altogether.  Furthermore, due to the 
recent advances in 3D printing technology, numerous different hard and soft materials could be 
printed simultaneously, allowing for multiple cell types and complex vasculature to be easily 
incorporated during a single print using only slight modifications to our approach. 
 
For this work, GelMA was chosen as our model hydrogel to encapsulate cells as it is a collagen 
derivative which contain RGD motifs necessary for cell adhesion, contains readily tunable 
mechanical properties, and exhibits high structural integrity for experiments lasting over one 
month.[42, 43]  Additionally, previous work has shown that GelMA properties such as diffusion, 
swelling, compressive moduli, and degree of crosslinking are highly consistent between batches, 
thereby reducing material variabilities which could affect experimental outcomes.[44-46] 
Furthermore, GelMA is capable of being UV crosslinked with minimal negative side effects to the 
encapsulated cells.[47, 48] PVA was chosen to be the sacrificial material and ABS was chosen to 
be the structural frame for our model system due to the fact that they both are commercially 
available thermoplastics capable of being printed at high fidelities using common 3D printers.  The 
selection of PVA allows for the possibility of printing user-defined channel-patterns for more 
complex tissue structures.  Additionally, post-processing removal of PVA from the system is also 
simplified as PVA is water soluble, thereby reducing the possibility for external contaminants to 
be introduced into the system via manual pipe removal. In this model a flow rate of 0.2 ml/hour 
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was used, a rate well below what would be needed in a larger construct containing primary 
cells.[49-51] The decision to use this lower rate was made, however, based on previous work that 
has shown how higher flow rates in in vitro bioreactor systems have led to significant increases in 
cell death and reduced cell proliferation.[52]  However, as the flow in this system is driven by a 
programmable syringe pump, further studies would easily be able to address this issue.  
 
It is known that mineralized matrix (in this case mineralized GelMA) is conducive to the diffusion 
of small solutes through interstitial spaces, albeit in the sub-nanometer range that cannot be 
observed with microCT.  After 2 and 4 weeks of perfusion, large voids in the deposited mineral 
were observed (Fig. 4.2E) that would allow for the diffusion of oxygen and other nutrients even 
after the formation of the mineralized crust. From the Live/Dead results (Fig. 4.2C), live cells 
could be seen outside the mineralized crust, indicating that diffusion of essential nutrients took 
place even after mineral formation. However, the crust did appear to inhibit the oxygen 
concentration away from the perfused pipes to a degree, as was qualitatively explained via 
COMSOL modeling (Fig. 4.6).  
 
This work represents a simple bioreactor system capable of inducing cell-mediated mineral 
deposition around perfusable channels. However, more work needs to be performed to create a 
completely mineralized thick bone construct as was indicated by the lack of mineralization 
between the pipes. The modularity of this model system allows for the incorporation of other cell 
types as well as the perfusion of growth factors with pulsatile perfusion conditions. One direction 
to enhance overall mineral formation is the co-encapsulation of vascular endothelial cells with 
bone cells in this system to facilitate the formation of perfusable microvasculature between printed 
channels. Increased perfusion rates as well as the incorporation of pulsatile flow and specific 
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growth factors can also be optimized within this model system. While long-term studies building 
upon the foundation of this model are necessary, this work provides early evidence that 3D printed, 
cell-laden hydrogels containing user defined channels can be used as a model system for bone 
tissue engineering applications. 
 
4.6 Conclusions 
 
Our study demonstrated that user-defined 3D printed channels could be used to promote mineral 
deposition within a diffusion-limited environment using commonly available 3D printers, 
sacrificial materials, and hydrogels. Based on these results, we anticipate that this technology could 
be easily scaled and reproduced in order to create thick, cell-laden constructs capable of serving 
as vascularized bone tissue substitutes, as well as be translated to other tissue engineering 
applications.  
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4.10 Supplementary figures 
 
 
Figure S4.1:  Polycarbonate base plate dimensions and scale. 
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Figure S4.2:  Polycarbonate top plate dimensions and scale. 
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Figure S4.3: Representative series of static and perfused images showing contrast of 
deposited mineral from background and frames after microCT scanning.  Representative 
whole views of in-tact constructs within 16mm diameter sample holders after scanning show 
contrast of deposited mineral (white) from background (grey) and sample frames (dark grey).  To 
normalize data, only mineralized pipes were contoured for mineral (ROI). 
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Figure S4.4:  Total mineral quantification.  Total mineral deposited around pipes after 1, 2, or 
4 weeks of both static osteogenic culture and osteogenic media perfusion showed significant 
increases in deposition after 4 weeks (4wk static and 4wk flow n=7, 2wk flow n=8, rest n=6.  * 
p<0.05 via one-way ANOVA). 
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CHAPTER 5:  ONGOING WORK AND FUTURE RECOMMENDATIONS 
 
5.1 Introduction 
 
The overarching goal of this work was to create a model bone tissue engineering construct that 
would support the numerous cellular interactions required for bone growth, provide potential 
structural support, and allow for nutrients to be delivered in a controlled, precise fashion via a user-
defined internal vasculature.  To achieve this goal, it was first necessary to identify a suitable soft 
matrix for cellular encapsulation and sustainable viability.  After identifying the soft matrix for 
cellular encapsulation, a way to combine the soft, cell-laden matrix with a hard, 3D printed 
structural support needed to be explored.  Finally, after combining the soft and hard components, 
the incorporation of a user defined perfusable vasculature was studied. 
 
In Chapter 2 of this work, osteoblast-like cells were encapsulated in GelMA hydrogels of varying 
density and chemically induced to produce mineral over the course of two weeks.  Although cells 
in the less dense gels had a higher overall viability and formed larger cellular clusters within the 
GelMA matrix, cells encapsulated within the denser constructs appeared to form more uniform 
mineral at the hydrogel periphery.  Moving forward, the dense gels were chosen to be more suitable 
as the base material for a model bone tissue engineering construct based on the mineralization 
results and literature suggesting that stiffer substrates promoted osteogenic differentiation and 
increased cell mediated mineralization.[1, 2]  However, based on the results from Chapter 4 of this 
work, the lack of pericellular material deposition between perfusable pipes could have been 
mitigated if the less dense hydrogels were used as the base material. 
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In Chapter 3 of this work, three different types of structural cages were 3D printed to serve as 
potential structural supports for the soft, cell-laden GelMA.  This chapter compared 
polycaprolactone (PCL) cages, polycaprolactone-hydroxyapatite (PCL-HA) composite cages, and 
polycaprolactone-poly lactic acid (PCL-PLA) composite cages and found that of the three, the 
PCL-PLA cages had the highest compressive strength.  However, none of the cages surpassed the 
compressive strength of a pure PLA cage alone.  Additionally, the print resolutions of the PLA 
cages were significantly higher than the PCL and PCL composites.  As a result, pure thermoplastic 
cages were chosen to be the supporting material for the cell-laden hydrogels going forward.  While 
PLA cages would have been optimal, purchasing issues required the use of acrylonitrile butadiene 
styrene (ABS) thermoplastic spools as a substitute for PLA. 
 
At the end of Chapter 3 it was shown that the cell-laden GelMA studied in Chapter 2 could be 
incorporated within the 3D printed cages via dropwise pipetting.  However, based on the live/dead 
imaging, it was hypothesized that the cellular density of living cells was not uniform throughout 
the entirety of the log-pile structure, most likely due to nutrient diffusion limitations in the center 
of the construct.  Accordingly, in Chapter 4 of this work it was decided that in order to increase 
cellular distribution throughout the construct and mitigate the hypothesized diffusion limitations, 
the 3D printed cage would not be log-pile in form but instead consist of an outside frame containing 
dissolvable 3D printed polyvinyl alcohol (PVA) pipes.  Upon casting the cell-laden GelMA into 
the 3D printed frame, the pipes were dissolved, leaving behind a fully perfusable, structurally 
supported cell-laden hydrogel.  However, sacrificing the log-pile structure for a rectangular cage 
would need to be addressed in any future work should the printed structure be used as a load-
bearing in vivo support. 
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While the structurally supported hydrogels from Chapter 4 could be perfused with osteogenic 
media for 1 month, the mineral deposition along the channel walls appeared to impede oxygen 
transfer into the surrounding GelMA matrix.  Furthermore, although the constructs could be scaled 
up into larger, 5 pipe arrays, little to no mineralization occurred between the channels.  As 
suggested previously, any future work would need to address the issue of mineralization between 
the perfusable pipes, most likely by changing the density of the hydrogel used to encapsulate the 
osteogenic cells. 
 
5.2 The addition of endothelial cells to the perfusable system 
 
Generally, monoculture systems for bone growth tend to be supplemented with growth factors like 
vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and bone 
morphogenetic protein (BMP).  However, while these supplements have been shown to promote 
mineralization and the formation of vasculature, they are prohibitively expensive and unwanted 
side effects such as in vitro tumor growth are common.[3-6]  Accordingly, as vascularization of 
the bone tissue constructs is desired, an alternative approach is to incorporate endothelial cells in 
the construct alongside osteogenic cells.[7-9]  
 
It has been shown that co-cultures of endothelial and osteogenic cells within tissue engineered 
constructs promote increased mineral deposition and vasculature creation.[10-12]  Autocrine and 
paracrine signaling between osteoblasts and endothelial cells is primarily modulated through the 
release of VEGF by osteoblasts and direct contact through gap junctions.[12-14]  The release of 
VEGF has been shown to stimulate vasculature formation through the recruitment of endothelial 
cells, which in turn has a complementary effect on osteoblasts as endothelial cells release pro-
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osteogenic cytokines such as BMP-2 and endothelin-1 that directly support osteoblast 
differentiation and mineralization.[15-19]  
 
Lining premade channels with endothelial cells is a common approach when making a vascularized 
tissue engineered construct, and seeded cells have shown the capability of forming a confluent 
cellular sheet along the channel lumens which selectively allow nutrients to pass into the bulk 
material.[20, 21]  Alternatively, encapsulated endothelial cells within hydrogels between premade 
vasculature channels have shown a high potential for vasculature creation in in vitro settings.[22]  
In one instance, encapsulated HUVECS within collagen gels rearranged into cords over the course 
of only 10 hours,[23] while HUVECS embedded within a fibrin gel containing supportive 
fibroblasts showed capillary formation between two larger, perfusable channels.[24] 
 
To investigate the addition of HUVECS in the model system presented in Chapter 4 of this work, 
HUVECS were either lined within the perfusable channels and surrounded by Saos-2 cells in the 
bulk GelMA or were added with the Saos-2 cells in a 2:1 ratio in the bulk (Fig. 5.1).  In order to 
line the channels with HUVECS, a cell suspension containing 25,000 HUVECS was pipetted 
dropwise into the channel, left to stand for 30 minutes, and repeated after flipping the construct.  
After two weeks of perfusion, channels lined with HUVECS had stunted mineral formation, while 
HUVECS added into the bulk significantly enhanced mineral deposition. 
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Figure 5.1:  MicroCT analysis of mineral deposition within a co-culture single pipe system.  
HUVECS (H) were either seeding along the perfusable channels (Channel) or added in a 2:1 ratio 
with Saos-2 cells in the GelMA matrix (Bulk) and were either perfused with osteogenic media 
(Flow) or left in static control wells (Static).  After two weeks of perfusion, HUVECS encapsulated 
in the bulk material significantly increased Saos-2 mineral deposition as compared to the 
constructs containing HUVEC lined channels and their static controls (* p<0.05 as compared to H 
Bulk Flow 2Wk, n=5). 
 
Due to the results presented in Fig. 5.1, the next step in expanding upon the model system 
described in this thesis is to encapsulate the osteoblast-like Saos-2 cells alongside HUVEC cells 
in a multi-pipe system in an attempt to enhance mineralization within the bulk GelMA between 
channels.  To that end, preliminary work has been performed in an expanded two pipe perfusable 
system similar to the model presented in Chapter 4.  Specifically, the one pipe system described 
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earlier has been extended to two pipes spaced 1mm apart in the x-y plane surrounded by a bulk 
GelMA matrix containing encapsulated Saos-2 cells and HUVECS (Fig. 5.2).  In the preliminary 
work, either HUVECS, Saos-2 Cells, or HUVECS with Saos-2 cells were encapsulated within a 
GelMA matrix and perfused with osteogenic media for either 1 or 2 weeks.  HUVECS and Saos-
2 cells were encapsulated at a 2:1 ratio (1 million HUVECS : 500,000 Saos-2).  After two weeks 
of perfusion, there was no significant increase in the mineral deposited in the Saos-2 only or Saos-
2/HUVEC constructs, however both had significantly more mineral deposition as compared to the 
one-week samples.  However, as the mineral recorded was the total mineral deposited in the entire 
construct, future work would include isolating only the mineral produced between the channels in 
order to quantify how HUVECS affect mineral formation between two nutrient supplies. 
 
Figure 5.2:  MicroCT analysis of mineral deposition within a co-culture double pipe system. 
HUVECS (H) were added in a 2:1 ratio with Saos-2 cells (S) in the GelMA matrix and perfused 
with osteogenic media for either 1 or 2 weeks.  After two weeks of perfusion, HUVEC+Saos-2 
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constructs did not show a significant increase in mineral deposition as compared to samples 
containing only Saos-2 cells.  (*p<0.05 as compared to S+H Flow 2Wk; $p<0.05 as compared to 
S Flow 2Wk; n=3 for HUVEC only samples, n=5 for rest). 
 
5.3 In vivo extension of model system 
 
The integration with host tissue remains a major obstacle facing any tissue engineered 
construct.[25-27]  In general, for complete integration to occur in an in vivo setting, any engineered 
construct needs to be biocompatible and show minimum immunogenicity.[28]  Furthermore, the 
challenge of either anastomosing or inosculating the construct with the host vasculature is a 
lengthy process that often results in implant failure, tissue necrosis, site inflammation, and local 
ischemia.[13, 29] 
 
Most work on integrating an implant with the host has relied on letting the host’s vasculature 
passively grow into the implant.  Unfortunately, approaches such as these could take many days 
to occur and complete anastomosis with the host is highly dependent on the geometry of the 
implant’s vasculature.[23, 30]   
 
In order to assess the biocompatibility of the model system presented in this work, preliminary 
ectopic implantation experiments were undertaken using our perfused constructs.  Specifically, 
6x6x6mm3 ABS frames were printed to house GelMA hydrogels containing primary mouse bone 
marrow skeletal stem cells (BMSC) and primary mouse vasculature endothelial cells (VEC).  The 
constructs were subsequently implanted subcutaneously in the dorsal pockets of C57BL/6J mice 
and retrieved after two weeks of implantation (Fig. 5.3).  As was expected, the constructs did show 
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some host ingrowth and blood invasion, as well as no signs of tissue inflammation or infection.  
Unfortunately, the constructs were inadvertently destroyed during the fixation and subsequent 
paraffin embedding process for histology, making the types of host ingrowth and cellular invasion 
impossible to elucidate. 
 
Figure 5.3:  Ectopic implantation of thermoplastic ABS frames containing primary BMSC 
and VEC cells. 6x6x6mm3 frames containing encapsulated BMSCs, VECs, or a combination of 
both were implanted subcutaneously in c57BL/6J mice (red arrows, top X-ray).  After two weeks 
of implantation, the implants were retrieved and showed blood invasion and minimal host 
ingrowth in the cell-laden constructs (bottom).* 
 
Based on the results of the preliminary ectopic implantation experiments, future work would be 
aimed at directly anastomosing the implant’s vasculature with the hosts blood supply (Fig. 5.4).  
Direct anastomosis would ensure that the perfusion of nutrients occurs at the time of implantation, 
thereby reducing the chance for implant failure and increasing the potential for host integration 
and encapsulated cell osteogenesis.[28]  However, as stated previously, the direct anastomosis 
                                                        
* All animal studies were performed at SUNY Upstate Medical University by Dr. Jason Horton under established and approved 
IACUC protocol. 
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process is highly risky and difficult, requiring extended practice and planning prior to 
implementation.  
 
Figure 5.4:  Cartoon depicting surgical anastomosis of perfusable structurally supported 
cell-laden constructs.  (A) 3D printed constructs containing cell-laden GelMA and perfusable 
channels will be anastomosed directly into the host femoral artery and sewn in place via 3D printed 
anchor grommets.  (B)  3D rendering of structural frame (blue) and stainless-steel catheter 
connections (grey).* 
 
 
 
 
                                                        
* Cartoon created by and used with permission from Dr. Jason Horton, SUNY Upstate Medical University. 
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5.4 Final Remarks 
 
This work has focused on creating a bone tissue engineering construct which could eventually 
serve as an in vivo implant to aid in regenerating lost bone.  While the model presented provides a 
promising avenue to explore, future work must be conducted to not only enhance nutrient transport 
and mineralization between the user defined macro-vasculature, but also to achieve implant 
integration with native tissue in an in vivo setting. 
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bone mineral formation.  SFB 2018 Annual Meeting.  April 2018.  Atlanta, GA.  Oral 
Presentation. 
 
2. Sawyer SW, Shridhar SV, Zhang K, Albrecht LD, Filip AB, Horton JA, Soman P.  Bone 
tissue engineering using 3D printing.  ORS 2018 Annual Meeting.  March 2018.  New 
Orleans, LA. 
 
3. Zhang K, Sawyer SW*, Albrecht LD, Ramos AS, Filip AB, Horton JA, Soman P.  Perfusion 
directed 3D bone mineral formation.  Biomedical Engineering Society (BMES) Annual 
Meeting.  October 2017.  Phoenix, AZ.  Oral Presentation. *1st Author. 
 
4. Filip AB, Albrecht LD, Sawyer SW, Soman P.  Multi-material hydrogel printing using an 
open-source 3D printer.  Biomedical Engineering Society (BMES) Annual Meeting.  October 
2017.  Phoenix, AZ. 
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2. Sawyer SW, Shridhar SV, Zhang K, Albrecht LD, Filip AB, Horton JA, Soman P.  Perfusion 
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5. Venn SA, Sawyer SW, Dong P, Ramos AR, Quinn D, Horton J, Soman P.  Encapsulation of 
saos-2 cells in conductive gelatin methacrylate hydrogels.  Syracuse Summer 2016 
Undergraduate Research Poster Session.  August 2016.  Syracuse, NY. 
 
6. Morton MK, Albrecht LD, Sawyer SW, Soman P.  Fabrication of hydrogel scaffolds with 
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7. Sawyer SW, Albrecht LD, Ramos AR, Oest ME, Margulies BS, Soman P. Engineering 
scaffolds for bone tissue engineering using cell-laden gelatin methacrylate hydrogels. 2016 
Stevenson Biomaterials Lecture and Research Poster Session. March 2016. Syracuse, NY. 
 
8. Sawyer SW, Aslan C, Chen YX, Margulies BS, Ogden KM, Henderson JH, Soman P. Bone 
regeneration using structurally reinforced stem cell-laden hydrogels. 2014 IGERT Retreat. 
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TEACHING ACTIVITIES 
 
Naval Nuclear Power Instructor (August 2005 – August 2008) 
Instructed and provided mentorship to over 400 junior enlisted sailors, instructed Mathematics 
and Reactor Principles, and managed a division of officer and enlisted personnel. 
 
PROFESSIONAL ACTIVITY 
 
Membership 
Society for Biomaterials (2016 – present) 
 
HONORS AND AWARDS 
 
ORISE Postdoctoral Fellowship 2018 
SBI Distinguished Ph.D. Student Research Award 2018 
Integrative Graduate Education and Research Traineeship Program Fellowship 2017 – 2018 
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Syracuse Biomaterials Institute Graduate Fellowship 2016 
Integrative Graduate Education and Research Traineeship Program Fellowship 2013 – 2015 
Navy and Marine Corps Achievement Medal 2007 
Navy Master Training Specialist 2007 
VMI Institute Scholarship 2001 – 2005 
 
